OBO_ID (LABEL):	UBERON_0001898 (hypothalamus)

ARTICLE	ARTICLE DATE	SENTENCE NUM	SENTENCE	IGNORANCE CATEGORIES	NUM IGNORANCE CATEGORIES	OBO ID (LABEL)
PMC2644268	3/2009	S16-PMC2644268	['it is one of the many survival reflexes organized and initiated in the Hypothalamus.']	N/A	N/A	[('UBERON_0001898', 'hypothalamus', 71, 'hypothalamus')]
PMC2671035	5/2009	S104-PMC2671035	['early Postnatal nutrition alters orexigenic Hypothalamic Agrp fiber density in Adult Life.']	N/A	N/A	[('GO_0007567', 'parturition', 6, 'postnatal'), ('UBERON_0001898', 'hypothalamus', 44, 'hypothalamic'), ('PR_000003580', 'ABI gene family member 3', 57, 'AgRP'), ('UBERON_0007023', 'adult organism', 79, 'adult'), ('UBERON_0000104', 'life cycle', 85, 'life')]
PMC2707610	7/2009	S6-PMC2707610	['Hypothalamic appetite regulators, and fuel (Glucose and Lipid) Metabolic markers were measured.']	N/A	N/A	[('UBERON_0001898', 'hypothalamus', 0, 'Hypothalamic'), ('CHEBI_17234', 'glucose', 44, 'glucose'), ('CHEBI_18059', 'lipid', 56, 'lipid'), ('GO_0008152', 'metabolic process', 63, 'metabolic')]
PMC2707610	7/2009	S20-PMC2707610	['Hypothalamic Npy concentrations are elevated before a meal to stimulate appetite, and continuous or repeated central administration of Npy leads readily to obesity, while Pomc derived α-Melanocyte-Stimulating Hormone (Msh) counteracts Npy to inhibit Feeding and promote negative energy balance[5].']	N/A	N/A	[('UBERON_0001898', 'hypothalamus', 0, 'Hypothalamic'), ('CHEBI_7440', 'NOP', 13, 'NPY'), ('PR_000011368', 'N-acetylneuraminate lyase', 13, 'NPY'), ('CHEBI_7440', 'NOP', 135, 'NPY'), ('PR_000011368', 'N-acetylneuraminate lyase', 135, 'NPY'), ('PR_000013030', 'NADPH--cytochrome P450 reductase', 171, 'POMC'), ('CL_0000148', 'melanocyte', 186, 'melanocyte'), ('PR_000010435', 'homeobox protein Mohawk', 186, 'melanocyte-stimulating hormone'), ('PR_000010687', 'homeobox protein MSX-2', 218, 'MSH'), ('PR_000011368', 'N-acetylneuraminate lyase', 235, 'NPY'), ('GO_0007631', 'feeding behavior', 250, 'feeding')]
PMC2707610	7/2009	S32-PMC2707610	['nutritional changes over this period modify the Expression of Appetite regulators and in offspring from obesity-prone Rats, the Hypothalamic Neuron Projections were shown to be permanently disrupted[16].']	N/A	N/A	[('GO_0010467', 'gene expression', 48, 'expression'), ('GO_0000239', 'pachytene', 62, 'appetite'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 118, 'rats'), ('CL_0000378', 'support cell (sensu Nematoda and Protostomia)', 128, 'hypothalamic neuron'), ('UBERON_0001898', 'hypothalamus', 128, 'hypothalamic'), ('GO_0043672', 'nexine', 141, 'neuron'), ('GO_0042995', 'cell projection', 148, 'projections')]
PMC2707610	7/2009	S33-PMC2707610	['hfd Feeding during Pregnancy increased the Proliferation of Hypothalamic Orexigenic peptide-Producing Neurons[17].']	N/A	N/A	[('GO_0007631', 'feeding behavior', 4, 'feeding'), ('GO_0007565', 'female pregnancy', 19, 'pregnancy'), ('GO_0008283', 'cell proliferation', 43, 'proliferation'), ('CL_0000286', 'hyphal cell', 60, 'hypothalamic'), ('UBERON_0001898', 'hypothalamus', 60, 'hypothalamic'), ('GO_0007608', 'sensory perception of smell', 73, 'orexigenic ...'), ('GO_0007128', 'meiotic prophase I', 92, 'producing'), ('CL_0000540', 'neuron', 102, 'neurons')]
PMC2707610	7/2009	S81-PMC2707610	['then Animals were killed by decapitation and the Hypothalamus was microdissected on ice into areas containing the Arcuate Nucleus (Arc), Paraventricular Nucleus (Pvn), and posterior Hypothalamus (ph).']	N/A	N/A	[('NCBITaxon_33208', 'Metazoa', 5, 'animals'), ('UBERON_0001898', 'hypothalamus', 49, 'hypothalamus'), ('UBERON_0002945', 'ventral posteromedial nucleus of thalamus', 114, 'arcuate nucleus'), ('UBERON_0000301', 'amniotic cavity', 131, 'Arc'), ('UBERON_0001930', 'paraventricular nucleus of hypothalamus', 137, 'paraventricular nucleus'), ('UBERON_0009910', 'posterior lateral plate mesoderm', 162, 'PVN'), ('UBERON_0001898', 'hypothalamus', 182, 'hypothalamus')]
PMC2707610	7/2009	S82-PMC2707610	['the anterior Hypothalamus was removed following coronal sections at the Optic Chiasm and 1.5 mm caudal.']	N/A	N/A	[('UBERON_0001898', 'hypothalamus', 13, 'hypothalamus'), ('UBERON_0000959', 'optic chiasma', 72, 'optic chiasm')]
PMC2707610	7/2009	S95-PMC2707610	['quantitative real-time pcr\ntotal rna was isolated from the Hypothalamus, rp fat, and Skeletal muscle using Trizol Reagent (invitrogen australia pty limited, melbourne, vic, australia).']	N/A	N/A	[('UBERON_0001898', 'hypothalamus', 59, 'hypothalamus'), ('UBERON_0004288', 'skeleton', 85, 'skeletal'), ('CHEBI_29021', 'hexane', 107, 'TriZol'), ('CHEBI_33893', 'reagent', 114, 'reagent')]
PMC2707610	7/2009	S217-PMC2707610	['5c).10.1371/journal.pone.0006259.g005\n\ncaption (fig): figure 5\nmrna Expression of Hypothalamic Appetite regulators at 18 weeks.']	N/A	N/A	[('GO_0010467', 'gene expression', 68, 'expression'), ('UBERON_0001898', 'hypothalamus', 82, 'hypothalamic'), ('GO_0000239', 'pachytene', 95, 'appetite')]
PMC2707610	7/2009	S218-PMC2707610	['(a) mrna Expression of Npy, (b) Y1 Receptor, (c) Agrp, (d) Pomc, (e, f) Mc4R and (g) crh in the Hypothalamus.']	N/A	N/A	[('GO_0010467', 'gene expression', 9, 'expression'), ('PR_000011368', 'N-acetylneuraminate lyase', 23, 'NPY'), ('PR_000001655', 'prostacyclin receptor', 32, 'Y1 receptor'), ('PR_000003580', 'ABI gene family member 3', 49, 'AgRP'), ('PR_000013030', 'NADPH--cytochrome P450 reductase', 59, 'POMC'), ('PR_000001244', 'long-wave-sensitive opsin 1', 72, 'MC4R'), ('UBERON_0001898', 'hypothalamus', 96, 'hypothalamus')]
PMC2707610	7/2009	S309-PMC2707610	['leptin is anorexigenic via inhibiting Hypothalamic Npy production and its action on Y1 Receptor[39].']	N/A	N/A	[('UBERON_0001898', 'hypothalamus', 38, 'hypothalamic'), ('PR_000011368', 'N-acetylneuraminate lyase', 51, 'NPY'), ('PR_000001655', 'prostacyclin receptor', 84, 'Y1 receptor')]
PMC2831965	1/2010	S74-PMC2831965	['decreases in the Serum levels of Thyroid hormones trigger a feedback system involving the Hypothalamus–Pituitary–Thyroid axis (nrc 2005).']	N/A	N/A	[('UBERON_0001977', 'blood serum', 17, 'serum'), ('CHEBI_9437', 'temoporfin', 33, 'thyroid'), ('UBERON_0002046', 'thyroid gland', 33, 'thyroid'), ('UBERON_0001898', 'hypothalamus', 90, 'hypothalamus'), ('UBERON_0002109', 'pair of nares', 103, 'pituitary'), ('UBERON_0002046', 'thyroid gland', 113, 'thyroid')]
PMC2831965	1/2010	S75-PMC2831965	['the Hypothalamus uses thyrotropin-releasing hormone (trh) to Control the Pituitary Gland, which in turn Controls the Thyroid through Thyroid-stimulating hormone (tsh).']	N/A	N/A	[('UBERON_0001898', 'hypothalamus', 4, 'hypothalamus'), ('GO_0065007', 'biological regulation', 61, 'control'), ('UBERON_0000007', 'pituitary gland', 73, 'pituitary gland'), ('GO_0065007', 'biological regulation', 104, 'controls'), ('UBERON_0002046', 'thyroid gland', 117, 'thyroid'), ('UBERON_0002046', 'thyroid gland', 133, 'thyroid')]
PMC3117679	5/2011	S5-PMC3117679	['results\ncompared to Mice Fed the control diets, the Expression of leptin in fat Tissue and leptin-r and Pomc in the Hypothalamus was higher in the diet-induced obesity (dio) Mice, and the n-3 Pufas in the diets reversed these elevated Expression levels.']	N/A	N/A	[('NCBITaxon_10088', 'Mus <genus>', 20, 'mice'), ('GO_0007631', 'feeding behavior', 25, 'fed'), ('GO_0010467', 'gene expression', 52, 'expression'), ('UBERON_0000479', 'tissue', 80, 'tissue'), ('PR_000013030', 'NADPH--cytochrome P450 reductase', 104, 'POMC'), ('UBERON_0001898', 'hypothalamus', 116, 'hypothalamus'), ('NCBITaxon_10088', 'Mus <genus>', 174, 'mice'), ('CHEBI_86926', 'S a S b S', 192, 'PUFAs'), ('GO_0010467', 'gene expression', 235, 'expression')]
PMC3117679	5/2011	S104-PMC3117679	['real-time quantitative rt-pcr was used to measure the mrna levels of leptin in Epididymal Fat and those of leptin-r, pomc and Npy in the Hypothalamus.']	N/A	N/A	[('UBERON_0004359', 'corpus epididymis', 79, 'epididymal fat'), ('PR_000011368', 'N-acetylneuraminate lyase', 126, 'NPY'), ('UBERON_0001898', 'hypothalamus', 137, 'hypothalamus')]
PMC3192420	7/2011	S15-PMC3192420	['they involve changes in leptin sensitivity (11) and Expression of a range of Hypothalamic neuromediators, including proopiomelanocortin, Neuropeptide Y (Npy), and the Melanocortin 4 receptor (Mc4R) (12).']	N/A	N/A	[('GO_0010467', 'gene expression', 52, 'expression'), ('UBERON_0001898', 'hypothalamus', 77, 'hypothalamic'), ('PR_000011469', 'high affinity nerve growth factor receptor', 137, 'neuropeptide Y'), ('PR_000011368', 'N-acetylneuraminate lyase', 153, 'NPY'), ('PR_000010435', 'homeobox protein Mohawk', 167, 'melanocortin'), ('PR_000001244', 'long-wave-sensitive opsin 1', 192, 'MC4R')]
PMC3192420	7/2011	S26-PMC3192420	['in the Hypothalamus and in peripheral Tissues, the Control Of Food Intake is Regulated through common Energy-Sensing pathways that integrate cellular energy concentration ( i.e .']	N/A	N/A	[('UBERON_0001898', 'hypothalamus', 7, 'hypothalamus'), ('UBERON_0000479', 'tissue', 38, 'tissues'), ('GO_0016477', 'cell migration', 51, 'control of food intake'), ('CHEBI_33290', 'food', 62, 'food'), ('GO_0065007', 'biological regulation', 77, 'regulated'), ('GO_0090505', 'epiboly involved in wound healing', 102, 'energy-sensing')]
PMC3192420	7/2011	S63-PMC3192420	['all the major Organs were weighed and representative samples snap frozen in liquid nitrogen and stored at −80 c as was the entire Hypothalamus of each Animal (10).']	N/A	N/A	[('UBERON_0000062', 'organ', 14, 'organs'), ('UBERON_0001898', 'hypothalamus', 130, 'hypothalamus'), ('NCBITaxon_33208', 'Metazoa', 151, 'animal')]
PMC3192420	7/2011	S67-PMC3192420	['total rna was extracted from entire Hypothalami, Abomasum, Omental, and Sc Adipose Tissue using the chomczynski and sacchi method (28,29) with deoxyribonuclease treatment (rneasy plus mini kit; qiagen, crawley, uk).']	N/A	N/A	[('UBERON_0001898', 'hypothalamus', 36, 'hypothalami'), ('UBERON_0007358', 'abomasum', 49, 'abomasum'), ('UBERON_0001091', 'calcareous tooth', 59, 'omental'), ('UBERON_0002483', 'trabecular bone tissue', 72, 'sc adipose tissue')]
PMC3192420	7/2011	S154-PMC3192420	['fold changes in mrna abundance in the Hypothalamus and Gastric Mucosa sampled from Adult offspring as measured at 17 months of agecararriugrpostnatal growthhypothalamus\u2003\u2003\u2003\u2003 ir 1.0 ± 0.241.2 ± 0.171.5 ± 0.30——\u2003\u2003\u2003\u2003 Ptp1B 1.0 ± 0.131.5 ± 0.121.5 ± 0.20<0.05—\u2003\u2003\u2003\u2003 Adnr1 1.0 ± 0.081.3 ± 0.141.1 ± 0.10——\u2003\u2003\u2003\u2003 Adnr2 1.0 ± 0.131.5 ± 0.131.4 ± 0.18<0.05—\u2003\u2003\u2003\u2003 obr 1.0 ± 0.190.9 ± 0.090.8 ± 0.15——\u2003\u2003\u2003\u2003 Socs3 1.0 ± 0.181.4 ± 0.221.6 ± 0.32——\u2003\u2003\u2003\u2003 ghsr 1.0 ± 0.131.1 ± 0.130.8 ± 0.08——\u2003\u2003\u2003\u2003 Agrp 1.0 ± 0.101.5 ± 0.131.2 ± 0.24——\u2003\u2003\u2003\u2003 mc4r 1.0 ± 0.151.1 ± 0.091.2 ± 0.14——\u2003\u2003\u2003\u2003 npy 1.0 ± 0.241.2 ± 0.240.7 ± 0.11——\u2003\u2003\u2003\u2003 Fto 1.0 ± 0.241.4 ± 0.121.4 ± 0.10<0.05—Stomach\u2003\u2003\u2003\u2003 ir 1.0 ± 0.110.7 ± 0.200.8 ± 0.16——\u2003\u2003\u2003\u2003 Glut1 1.0 ± 0.151.0 ± 0.453.2 ± 0.42—<0.01\u2003\u2003\u2003\u2003 Obr 1.0 ± 0.610.5 ± 0.223.4 ± 1.00—<0.001\u2003\u2003\u2003\u2003 leptin 1.0 ± 0.342.8 ± 1.082.5 ± 1.10——\u2003\u2003\u2003\u2003 Ghrelin 1.0 ± 0.321.7 ± 0.391.6 ± 0.52——\u2003\u2003\u2003\u2003 acc α1.0 ± 0.140.9 ± 0.313.7 ± 0.87—<0.05\u2003\u2003\u2003\u2003 Sirt1 1.0 ± 0.090.7 ± 0.080.7 ± 0.10<0.05—\u2003\u2003\u2003\u2003 Dnmt1 1.0 ± 0.080.8 ± 0.213.3 ± 0.70—<0.01\u2003\u2003\u2003\u2003 fto 1.0 ± 0.251.1 ± 0.355.2 ± 1.06—<0.001\nvalues are means ±sem.']	N/A	N/A	[('UBERON_0001898', 'hypothalamus', 38, 'hypothalamus'), ('UBERON_0001199', 'mucosa of stomach', 55, 'gastric mucosa'), ('UBERON_0007023', 'adult organism', 83, 'adult'), ('PR_000013453', 'tyrosine-protein phosphatase non-receptor type 18', 213, 'PTP1B'), ('PR_000000067', 'activin receptor type-1', 260, 'AdnR1'), ('PR_000000067', 'activin receptor type-1', 303, 'AdnR2'), ('PR_000015399', 'superoxide dismutase [Cu-Zn]', 391, 'SOCS3'), ('PR_000003680', 'actin, cytoplasmic 2', 476, 'AgRP 1'), ('UBERON_0013078', 'venom-injecting tooth', 601, 'FTO'), ('UBERON_0000945', 'stomach', 641, 'Stomach'), ('PR_000015065', 'solute carrier family 2, facilitated glucose transporter member 3', 693, 'GLUT1'), ('UBERON_0002828', 'ventral cochlear nucleus', 740, 'ObR'), ('PR_000007874', 'guanylate-binding protein 1', 830, 'Ghrelin 1'), ('PR_000014888', 'NAD-dependent protein deacetylase sirtuin-1', 921, 'SIRT1'), ('PR_000006564', 'dynein heavy chain 5, axonemal', 968, 'DNMT1')]
PMC3192420	7/2011	S158-PMC3192420	['in the Hypothalamus, maternal r resulted in raised Gene Expression for the Mc3R , Ampk Α, mtor , Ptp1B , Adnr2 , and the fto Gene (table 3andfig.']	N/A	N/A	[('UBERON_0001898', 'hypothalamus', 7, 'hypothalamus'), ('GO_0010467', 'gene expression', 51, 'gene expression'), ('SO_0000704', 'gene', 51, 'gene'), ('PR_000001244', 'long-wave-sensitive opsin 1', 75, 'MC3R'), ('PR_000004510', 'ataxin-7-like protein 2', 82, 'AMPK α'), ('PR_000013453', 'tyrosine-protein phosphatase non-receptor type 18', 97, 'PTP1B'), ('PR_000000067', 'activin receptor type-1', 105, 'AdnR2'), ('SO_0000704', 'gene', 125, 'gene')]
PMC3202114	10/2011	S140-PMC3202114	['administration of either Dexamethasone or Carbenoxolone (to inhibit 11 Β -Hydroxysteroid Dehydrogenase Type 2) to normal Pregnant Rats also causes fetal growth retardation and the Adult offspring are hypertensive and hyperglycemic, with hyperactive Hypothalamic-Pituitary-Adrenal axis [115].']	N/A	N/A	[('CHEBI_41879', 'dexamethasone', 25, 'dexamethasone'), ('CHEBI_51687', 'chrysene', 42, 'carbenoxolone'), ('CHEBI_36844', '7-hydroxy steroid', 71, 'β -hydroxysteroid'), ('PR_000009658', 'laminin subunit gamma-1', 71, 'β -hydroxysteroid dehydrogenase type 2'), ('GO_0007565', 'female pregnancy', 121, 'pregnant'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 130, 'rats'), ('UBERON_0007023', 'adult organism', 180, 'adult'), ('UBERON_0001898', 'hypothalamus', 249, 'hypothalamic'), ('UBERON_0002109', 'pair of nares', 262, 'pituitary'), ('UBERON_0002369', 'adrenal gland', 272, 'adrenal')]
PMC3264579	1/2012	S63-PMC3264579	["after removal of the Brain from the Skull, Hypothalamus was dissected, according to paxino's atlas coordinates: −1.0 mm to −4.5 mm from bregma and 3 mm in depth[23]on ice tray, snapped frozen in liquid nitrogen and stored at −80°c."]	N/A	N/A	[('UBERON_0000955', 'brain', 21, 'brain'), ('UBERON_0003129', 'skull', 36, 'skull'), ('UBERON_0001898', 'hypothalamus', 43, 'hypothalamus')]
PMC3264579	1/2012	S66-PMC3264579	['fifty µg of Hypothalamic protein extract were suspended in sample buffer with 5% 2-Mercaptoethanol, and boiled for 5 min.']	N/A	N/A	[('UBERON_0001898', 'hypothalamus', 12, 'hypothalamic'), ('CHEBI_41218', 'mercaptoethanol', 81, '2-mercaptoethanol')]
PMC3264579	1/2012	S75-PMC3264579	['rna isolation and real time rt-pcr\nrna was isolated from snap-frozen Hypothalamus using the nucleospin® rna/protein kit (macherey-nagel, eurl, hoerdt, france).']	N/A	N/A	[('UBERON_0001898', 'hypothalamus', 69, 'hypothalamus')]
PMC3264579	1/2012	S152-PMC3264579	['western blot analysis of (a) phosphorylated and total Stat3, (b) pakt/Akt, (c) Pmtor/mtor, in Hypothalamic protein extracts from 5 months-old cc, rc and rr Rats after saline or leptin (1 mg/kg) Intraperitoneal injection.']	N/A	N/A	[('PR_000015700', 'alpha-2,8-sialyltransferase 8F', 54, 'STAT3'), ('PR_000003888', 'A-kinase anchor protein 14', 70, 'AKT'), ('PR_000013199', 'prolargin', 79, 'pmTOR'), ('UBERON_0001898', 'hypothalamus', 94, 'hypothalamic'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 156, 'rats'), ('UBERON_2001932', 'sensory canal tubular ossicle', 194, 'intraperitoneal')]
PMC3264579	1/2012	S162-PMC3264579	['no difference was measured in cc and rc Rats for the Expression of Hypothalamic Lepra and Leprb mrna.']	N/A	N/A	[('NCBITaxon_9986', 'Oryctolagus cuniculus', 40, 'rats'), ('GO_0010467', 'gene expression', 53, 'expression'), ('UBERON_0001898', 'hypothalamus', 67, 'hypothalamic'), ('PR_000009659', 'laminin subunit gamma-2', 80, 'LepRa'), ('PR_000002059', 'lymphotactin-like chemokine', 90, 'LepRb')]
PMC3264579	1/2012	S165-PMC3264579	['5b) mrna was observed in rr Hypothalami compared to cc and rc Rats.10.1371/journal.pone.0030616.g005\n\ncaption (fig): figure 5\nHypothalamic Expression of leptin receptors.']	N/A	N/A	[('UBERON_0001898', 'hypothalamus', 28, 'hypothalami'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 62, 'rats'), ('UBERON_0001898', 'hypothalamus', 126, 'Hypothalamic'), ('GO_0010467', 'gene expression', 139, 'expression')]
PMC3264579	1/2012	S166-PMC3264579	['(a) relative Hypothalamic Leprb and (b) Lepra mrna Expression.']	N/A	N/A	[('UBERON_0001898', 'hypothalamus', 13, 'hypothalamic'), ('PR_000002059', 'lymphotactin-like chemokine', 26, 'LepRb'), ('PR_000009659', 'laminin subunit gamma-2', 40, 'LepRa'), ('GO_0010467', 'gene expression', 51, 'expression')]
PMC3264579	1/2012	S196-PMC3264579	['leptin stimulates phosphorylation of Ribosomal s6 kinase (S6K), a major physiological substrate for mtor kinase in the Hypothalamus[19]but fasting inhibits it.']	N/A	N/A	[('GO_0005840', 'ribosome', 37, 'ribosomal'), ('PR_000000124', 'ribosomal protein S6 kinase beta-2', 58, 'S6K'), ('UBERON_0001898', 'hypothalamus', 119, 'hypothalamus')]
PMC3264579	1/2012	S201-PMC3264579	['in addition to alteration of signalling pathways rr Rats Hypothalami displayed a significant reduction of the long form leptin receptor (Leprb) mrna and leptin transporter (Lepra) mrna.']	N/A	N/A	[('NCBITaxon_9986', 'Oryctolagus cuniculus', 52, 'rats'), ('UBERON_0001898', 'hypothalamus', 57, 'hypothalami'), ('PR_000002059', 'lymphotactin-like chemokine', 137, 'LepRb'), ('PR_000009659', 'laminin subunit gamma-2', 173, 'LepRa')]
PMC3271107	2/2012	S5-PMC3271107	['these changes in Pomc cells occurred in the absence of marked changes in humoral factors or Hypothalamic npy Neurons.']	N/A	N/A	[('PR_000013508', 'PX domain-containing protein kinase-like protein', 17, 'Pomc'), ('CL_0000286', 'hyphal cell', 92, 'hypothalamic'), ('UBERON_0001898', 'hypothalamus', 92, 'hypothalamic'), ('CL_0000540', 'neuron', 109, 'neurons')]
PMC3271107	2/2012	S7-PMC3271107	['the Pancreatic hormone Insulin relays peripheral anabolic signals to the Hypothalamic Control center[1].']	N/A	N/A	[('UBERON_0001264', 'pancreas', 4, 'pancreatic'), ('PR_000045358', 'insulin family protein', 23, 'insulin'), ('UBERON_0001898', 'hypothalamus', 73, 'hypothalamic'), ('GO_0065007', 'biological regulation', 86, 'control')]
PMC3271107	2/2012	S8-PMC3271107	['Insulin Receptors (insr) are widely Expressed in the Brain, with the highest concentrations in the Olfactory Bulb, hippocampus, Cerebral Cortex, Cerebellum, and Hypothalamus[2],[3].']	N/A	N/A	[('PR_000001365', 'interleukin-10 receptor subunit alpha', 0, 'Insulin receptors'), ('GO_0010467', 'gene expression', 36, 'expressed'), ('UBERON_0000955', 'brain', 53, 'brain'), ('GO_0007608', 'sensory perception of smell', 99, 'olfactory'), ('UBERON_0002264', 'olfactory bulb', 99, 'olfactory bulb'), ('UBERON_0000956', 'cerebral cortex', 128, 'cerebral cortex'), ('UBERON_0002037', 'cerebellum', 145, 'cerebellum'), ('UBERON_0001898', 'hypothalamus', 161, 'hypothalamus')]
PMC3271107	2/2012	S32-PMC3271107	['these Mice have a >95% reduction of insr levels in the arc ( figure 1 ) and blunted Insulin Signaling in both Hypothalamic Cell extracts and arc Neurons in vivo [7],[18],[19].']	N/A	N/A	[('NCBITaxon_10088', 'Mus <genus>', 6, 'mice'), ('GO_0031129', 'inductive cell-cell signaling', 84, 'insulin signaling'), ('PR_000045358', 'insulin family protein', 84, 'insulin'), ('CL_0000632', 'hepatic stellate cell', 110, 'hypothalamic cell'), ('UBERON_0001898', 'hypothalamus', 110, 'hypothalamic'), ('CL_0000540', 'neuron', 145, 'neurons')]
PMC3355854	3/2012	S5-PMC3355854	['in physiological terms, the process consists of activation of the Hypothalamic–Pituitary–Gonadal (Hpg) axis, which leads to the production of sex Steroids and mature Gametes as well as the ability to Reproduce (watanabe and terasawa,1989; sisk et al.,2001; harris and levine,2003).']	N/A	N/A	[('UBERON_0001898', 'hypothalamus', 66, 'hypothalamic'), ('UBERON_0002109', 'pair of nares', 79, 'pituitary'), ('UBERON_0000991', 'gonad', 89, 'gonadal'), ('UBERON_0009889', 'secondary heart field', 98, 'HPG'), ('CHEBI_35341', 'steroid', 146, 'steroids'), ('CL_0000300', 'gamete', 166, 'gametes'), ('GO_0000003', 'reproduction', 200, 'reproduce')]
PMC3355854	3/2012	S191-PMC3355854	['additionally, Hypothalamic Kiss1 mrna levels are reduced in ob/ob Mice (smith et al.,2006a; quennell et al.,2011) and Streptozotocin-induced diabetic Rats (castellano et al.,2006,2009).']	N/A	N/A	[('UBERON_0001898', 'hypothalamus', 14, 'hypothalamic'), ('PR_000009224', 'junctophilin-3', 27, 'Kiss1'), ('NCBITaxon_10088', 'Mus <genus>', 66, 'mice'), ('CHEBI_9288', 'streptozocin', 118, 'streptozotocin'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 150, 'rats')]
PMC3365381	3/2011	S99-PMC3365381	['in Animal and Human experiments, the change of the Perinatal methylation pattern in depression alters the Hypothalamic-Pituitary-Adrenal axis (oberlander et al.2008).']	N/A	N/A	[('NCBITaxon_33208', 'Metazoa', 3, 'animal'), ('NCBITaxon_9606', 'Homo sapiens', 14, 'human'), ('GO_0036268', 'swimming', 51, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 51, 'perinatal'), ('UBERON_0001898', 'hypothalamus', 106, 'hypothalamic'), ('UBERON_0002109', 'pair of nares', 119, 'pituitary'), ('UBERON_0002369', 'adrenal gland', 129, 'adrenal')]
PMC3382418	6/2012	S9-PMC3382418	['Hypothalamic Ob-Rb Expression was increased in cr, hc, and hf offspring (+33–100% vs ca; p \u2009<\u20090.05 or less).']	N/A	N/A	[('UBERON_0001898', 'hypothalamus', 0, 'Hypothalamic'), ('PR_000012086', 'homeobox protein OTX2', 13, 'Ob-'), ('PR_000013773', 'retinoblastoma-associated protein', 16, 'Rb'), ('GO_0010467', 'gene expression', 19, 'expression')]
PMC3382418	6/2012	S96-PMC3382418	['briefly, coronal cryostat sections (20\u2009μm) of Hypothalamic Brain Tissue were cut from eight Brains in each group.']	N/A	N/A	[('UBERON_0001898', 'hypothalamus', 46, 'hypothalamic'), ('UBERON_0000955', 'brain', 59, 'brain'), ('UBERON_0000479', 'tissue', 65, 'tissue'), ('UBERON_0000955', 'brain', 92, 'brains')]
PMC3382418	6/2012	S97-PMC3382418	['Hypothalamic sections were collected onto slides, with adjacent sections on consecutively numbered slides.']	N/A	N/A	[('UBERON_0001898', 'hypothalamus', 0, 'Hypothalamic')]
PMC3382418	6/2012	S98-PMC3382418	['this permitted Ob-Rb mrna to be localized and quantified in the Arcuate Nucleus (arc) of the Hypothalamus.']	N/A	N/A	[('PR_000011633', 'oligodendrocyte transcription factor 3', 15, 'Ob-Rb'), ('UBERON_0002945', 'ventral posteromedial nucleus of thalamus', 64, 'arcuate nucleus'), ('UBERON_0001898', 'hypothalamus', 93, 'hypothalamus')]
PMC3382418	6/2012	S140-PMC3382418	['Plasma leptin and Hypothalamic leptin receptor Expression in Adult Rats\nplasma leptin levels and Expression of the long form of the leptin receptor (Ob-Rb) in the arc of the Hypothalamus are shown in figure5.']	N/A	N/A	[('UBERON_0001969', 'blood plasma', 0, 'Plasma'), ('UBERON_0001898', 'hypothalamus', 18, 'hypothalamic'), ('GO_0010467', 'gene expression', 47, 'expression'), ('UBERON_0007023', 'adult organism', 61, 'adult'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 67, 'rats'), ('GO_0010467', 'gene expression', 97, 'expression'), ('PR_000011633', 'oligodendrocyte transcription factor 3', 149, 'Ob-Rb'), ('UBERON_0001898', 'hypothalamus', 174, 'hypothalamus')]
PMC3382418	6/2012	S148-PMC3382418	['caption (fig): figure 6\n\ncorrelations between fat depot weights and leptin (a,b), fat depot weight and Hypothalamic leptin receptor (Ob-Rb) Expression (c), and Ob-Rb Expression and leptin (d) in Adult offspring from dams Fed during Gestation either a control diet ad libitum , or a control, a high-fat, or a high-Carbohydrate diet ad libitum for 6\u2009h during the light period, in addition to two normal meals given during the dark period .']	N/A	N/A	[('UBERON_0001898', 'hypothalamus', 103, 'hypothalamic'), ('PR_000011633', 'oligodendrocyte transcription factor 3', 133, 'Ob-Rb'), ('GO_0010467', 'gene expression', 140, 'expression'), ('PR_000011633', 'oligodendrocyte transcription factor 3', 160, 'Ob-Rb'), ('GO_0010467', 'gene expression', 166, 'expression'), ('UBERON_0007023', 'adult organism', 195, 'adult'), ('GO_0007631', 'feeding behavior', 221, 'fed'), ('GO_0007565', 'female pregnancy', 232, 'gestation'), ('CHEBI_16730', 'chloramphenicol 3-acetate', 313, 'carbohydrate')]
PMC3411795	8/2012	S82-PMC3411795	['in the Th1 -mo1 morphant Brain we observed reduced th immunoreactivity (th-ir) in the Olfactory Bulb, subpallium, the Ventral Diencephalon, including the Posterior Tuberculum, the lateral and dorsal Hypothalamus, and the locus coeruleus.']	N/A	N/A	[('PR_000024069', 'threonyl-tRNA synthetase', 7, 'th1'), ('UBERON_0000955', 'brain', 25, 'brain'), ('GO_0007608', 'sensory perception of smell', 86, 'olfactory'), ('UBERON_0002264', 'olfactory bulb', 86, 'olfactory bulb'), ('UBERON_0000204', 'ventral part of telencephalon', 118, 'ventral diencephalon'), ('UBERON_2000633', 'caudal tuberculum', 154, 'posterior tuberculum'), ('UBERON_0001898', 'hypothalamus', 199, 'hypothalamus')]
PMC3411795	8/2012	S137-PMC3411795	['by 3 dpf, most of the Da Cell groups and Circuits described in the Adult Brain are well established[44],[45], with Da Cell clusters formed in the Olfactory Bulb, Pretectum, Retina, and the Ventral Diencephalon including the posterior tuberculum, Thalamus and Hypothalamus.']	N/A	N/A	[('CL_0000502', 'type D enteroendocrine cell', 22, 'DA cell'), ('UBERON_0024914', 'circuit part of central nervous system', 41, 'circuits'), ('UBERON_0007023', 'adult organism', 67, 'adult'), ('UBERON_0000955', 'brain', 73, 'brain'), ('CL_0000502', 'type D enteroendocrine cell', 115, 'DA cell'), ('GO_0007608', 'sensory perception of smell', 146, 'olfactory'), ('UBERON_0002264', 'olfactory bulb', 146, 'olfactory bulb'), ('UBERON_0001944', 'pretectal region', 162, 'pretectum'), ('UBERON_0000966', 'retina', 173, 'retina'), ('UBERON_0000204', 'ventral part of telencephalon', 189, 'ventral diencephalon'), ('UBERON_0001897', 'dorsal plus ventral thalamus', 246, 'thalamus'), ('UBERON_0001898', 'hypothalamus', 259, 'hypothalamus')]
PMC3478561	11/2012	S22-PMC3478561	['the Hypothalamus undergoes robust growth that begins in early Gestation and continues through Postnatal Life (22).']	N/A	N/A	[('UBERON_0001898', 'hypothalamus', 4, 'hypothalamus'), ('GO_0007565', 'female pregnancy', 62, 'gestation'), ('GO_0007567', 'parturition', 94, 'postnatal'), ('UBERON_0000104', 'life cycle', 104, 'life')]
PMC3478561	11/2012	S23-PMC3478561	['Hypothalamic Neurogenesis occurs in rodents during Midgestation, whereas the neural Projections between different nuclei develop during early Postnatal Life (23).']	N/A	N/A	[('UBERON_0001898', 'hypothalamus', 0, 'Hypothalamic'), ('GO_0022008', 'neurogenesis', 13, 'neurogenesis'), ('GO_0007567', 'parturition', 51, 'midgestation'), ('GO_0042995', 'cell projection', 84, 'projections'), ('GO_0007567', 'parturition', 142, 'postnatal'), ('UBERON_0000104', 'life cycle', 152, 'life')]
PMC3478561	11/2012	S223-PMC3478561	['ampk and acc in the Hypothalamus are dephosphorylated in response to leptin activation Of Stat3 Signaling, and the resulting decreases in pampk and pacc in the Hypothalamus inhibit food Intake in Adult Rats (34–37).']	N/A	N/A	[('UBERON_0001898', 'hypothalamus', 20, 'hypothalamus'), ('GO_0008355', 'olfactory learning', 87, 'of ... signaling'), ('PR_000015700', 'alpha-2,8-sialyltransferase 8F', 90, 'STAT3'), ('UBERON_0001898', 'hypothalamus', 160, 'hypothalamus'), ('GO_0007631', 'feeding behavior', 186, 'intake'), ('UBERON_0007023', 'adult organism', 196, 'adult'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 202, 'rats')]
PMC3496584	7/2012	S97-PMC3496584	['stress typically results in secretion of Corticotropin-releasing hormone (Crh) from the Hypothalamus and Regulates the Hypothalamic-Pituitary-Adrenal (hpa) axis [100].']	N/A	N/A	[('CHEBI_3918', 'crocetin', 41, 'corticotropin'), ('PR_000005890', 'crooked neck-like protein 1', 41, 'corticotropin'), ('PR_000005864', 'protein CREG2', 74, 'CRH'), ('UBERON_0001898', 'hypothalamus', 88, 'hypothalamus'), ('GO_0065007', 'biological regulation', 105, 'regulates'), ('UBERON_0001898', 'hypothalamus', 119, 'hypothalamic'), ('UBERON_0002109', 'pair of nares', 132, 'pituitary'), ('UBERON_0002369', 'adrenal gland', 142, 'adrenal')]
PMC3504314	11/2012	S142-PMC3504314	['permanent structural changes in key Organs during critical periods of development\n\nHypothalamic reprogramming in offspring by maternal under-nutrition\nthe Hypothalamus is the centre that integrates peripheral and central signals to Regulate Metabolic status via the Modulation of Expression of energy-Regulating peptides (schwartz et al.,2000).']	N/A	N/A	[('UBERON_0000062', 'organ', 36, 'organs'), ('UBERON_0001898', 'hypothalamus', 83, 'Hypothalamic'), ('UBERON_0001898', 'hypothalamus', 155, 'hypothalamus'), ('GO_0065007', 'biological regulation', 232, 'regulate'), ('GO_0008152', 'metabolic process', 241, 'metabolic'), ('GO_0065007', 'biological regulation', 266, 'modulation'), ('GO_0010467', 'gene expression', 280, 'expression'), ('GO_0065007', 'biological regulation', 301, 'regulating')]
PMC3504314	11/2012	S145-PMC3504314	['the Hypothalamus consists of several nuclei; Arcuate Nucleus (Arc), Paraventricular Nucleus (Pvn), Dorsomedial Hypothalamus (dmh), ventromedial hypothalamus (vmh), and Lateral Hypothalamic areas (lha).']	N/A	N/A	[('UBERON_0001898', 'hypothalamus', 4, 'hypothalamus'), ('UBERON_0002945', 'ventral posteromedial nucleus of thalamus', 45, 'arcuate nucleus'), ('UBERON_0004356', 'apical ectodermal ridge', 62, 'ARC'), ('UBERON_0001930', 'paraventricular nucleus of hypothalamus', 68, 'paraventricular nucleus'), ('UBERON_0009910', 'posterior lateral plate mesoderm', 93, 'PVN'), ('UBERON_2000347', 'dorsal zone of median tuberal portion of hypothalamus', 99, 'dorsomedial hypothalamus'), ('UBERON_2000224', 'quadrate ventral process', 168, 'lateral hypothalamic')]
PMC3504314	11/2012	S151-PMC3504314	['abbreviations: Agrp, Agouti-Related Peptide; arc, Arcuate nucleus; cart, Cocaine-related and Amphetamine-Regulated Transcript; d, day; g, Gestation; Ht, Hypothalamus; l, lactation; lha, lateral Hypothalamic areas; msh, Α-Melanocyte-stimulating hormone; m, month; pomc, pro-opiomelanocortin; Pvn, Paraventricular Nucleus; vmh, ventromedial hypothalamus.']	N/A	N/A	[('PR_000003580', 'ABI gene family member 3', 15, 'AgRP'), ('PR_000003890', 'A-kinase anchor protein 3', 21, 'agouti-related peptide'), ('UBERON_0001876', 'amygdala', 50, 'arcuate'), ('CHEBI_33011', 'manganide', 73, 'cocaine'), ('CHEBI_2687', 'amsacrine', 93, 'amphetamine'), ('GO_0065007', 'biological regulation', 105, 'regulated'), ('SO_0000673', 'transcript', 115, 'transcript'), ('GO_0007565', 'female pregnancy', 138, 'gestation'), ('UBERON_0001450', 'calcaneus', 149, 'HT'), ('UBERON_0001898', 'hypothalamus', 153, 'hypothalamus'), ('UBERON_0001898', 'hypothalamus', 194, 'hypothalamic'), ('CL_0002052', 'Fraction D precursor B cell', 219, 'α ...'), ('CL_0000148', 'melanocyte', 221, 'melanocyte'), ('UBERON_0009910', 'posterior lateral plate mesoderm', 291, 'PVN'), ('UBERON_0001930', 'paraventricular nucleus of hypothalamus', 296, 'paraventricular nucleus')]
PMC3504314	11/2012	S156-PMC3504314	['more severe Food restriction (50% calorie restriction during Pregnancy and Lactation) resulted in an increase in Cell Proliferation in Pvn, vmh, and arc Hypothalamic areas of pups (coupe et al.,2009a), as well as reduced Pomc Neuron Fiber Projections from the Arc to the Pvn (delahaye et al.,2008).']	N/A	N/A	[('CHEBI_33290', 'food', 12, 'food'), ('GO_0007565', 'female pregnancy', 61, 'pregnancy'), ('GO_0007595', 'lactation', 75, 'lactation'), ('GO_0008283', 'cell proliferation', 113, 'cell proliferation'), ('UBERON_0009910', 'posterior lateral plate mesoderm', 135, 'PVN'), ('UBERON_0001898', 'hypothalamus', 153, 'hypothalamic'), ('PR_000013030', 'NADPH--cytochrome P450 reductase', 221, 'POMC'), ('CL_0000540', 'neuron', 226, 'neuron'), ('GO_0043672', 'nexine', 226, 'neuron'), ('GO_0005921', 'gap junction', 233, 'fiber projections'), ('UBERON_0004356', 'apical ectodermal ridge', 260, 'ARC'), ('UBERON_0009910', 'posterior lateral plate mesoderm', 271, 'PVN')]
PMC3504314	11/2012	S161-PMC3504314	['moderate maternal calorie restriction during the first 12 days of Gestation resulted in lower Expression levels of Npy (in females) and Agrp (both sexes) in the Hypothalamus at weaning (garcia et al.,2010).']	N/A	N/A	[('GO_0007565', 'female pregnancy', 66, 'gestation'), ('GO_0010467', 'gene expression', 94, 'expression'), ('PR_000011368', 'N-acetylneuraminate lyase', 115, 'NPY'), ('PR_000003580', 'ABI gene family member 3', 136, 'AgRP'), ('UBERON_0001898', 'hypothalamus', 161, 'hypothalamus')]
PMC3504314	11/2012	S164-PMC3504314	['no changes in the Hypothalamic Expression of Npy were observed in offspring of 50% calorie-restricted mothers during Pregnancy and Lactation (delahaye et al.,2008).']	N/A	N/A	[('UBERON_0001898', 'hypothalamus', 18, 'hypothalamic'), ('GO_0010467', 'gene expression', 31, 'expression'), ('PR_000011368', 'N-acetylneuraminate lyase', 45, 'NPY'), ('GO_0007565', 'female pregnancy', 117, 'pregnancy'), ('GO_0007595', 'lactation', 131, 'lactation')]
PMC3504314	11/2012	S170-PMC3504314	['offspring from 50% Food-restricted dams showed reduced leptin-induced Stat3 phosphorylation at 1-day-old and impaired Anorexigenic response to leptin, together with lower Hypothalamic leptin receptor Expression levels later in Life (at 3 weeks of age) (desai et al.,2007b).']	N/A	N/A	[('CHEBI_33290', 'food', 19, 'food'), ('PR_000015700', 'alpha-2,8-sialyltransferase 8F', 70, 'STAT3'), ('GO_0001525', 'angiogenesis', 118, 'anorexigenic'), ('UBERON_0001898', 'hypothalamus', 171, 'hypothalamic'), ('GO_0010467', 'gene expression', 200, 'expression'), ('UBERON_0000104', 'life cycle', 227, 'life')]
PMC3504314	11/2012	S172-PMC3504314	['in addition, decreased Expression levels of Hypothalamic leptin receptor were also observed in Adult offspring of calorie-restricted dams (desai et al.,2007b; palou et al.,2012), together with an altered response of leptin and Insulin receptors to fasting conditions (breton et al.,2009).']	N/A	N/A	[('GO_0010467', 'gene expression', 23, 'expression'), ('UBERON_0001898', 'hypothalamus', 44, 'hypothalamic'), ('UBERON_0007023', 'adult organism', 95, 'adult'), ('PR_000045358', 'insulin family protein', 227, 'insulin')]
PMC3518064	11/2012	S129-PMC3518064	['leptin mainly acts by binding to specific central and peripheral receptors in the Hypothalamus, Adipose Tissue, Liver, and Pancreatic Β -Cells [97].']	N/A	N/A	[('UBERON_0001898', 'hypothalamus', 82, 'hypothalamus'), ('UBERON_0001013', 'adipose tissue', 96, 'adipose tissue'), ('UBERON_0002107', 'liver', 112, 'liver'), ('CL_0000173', 'pancreatic D cell', 123, 'pancreatic β -cells'), ('UBERON_0001264', 'pancreas', 123, 'pancreatic')]
PMC3527219	11/2012	S13-PMC3527219	['also in domestic pigs, Prenatally stressed offspring displayed altered Hypothalamic-Pituitary-Adrenal (hpa) axis Regulation [6,7], suppressed humoral and cellular immune responses [8,9], increased Cortisol levels after social mixing [10,11] and stronger fever and cytokine responses to an inflammatory stimulus [12,13].']	N/A	N/A	[('GO_0019230', 'proprioception', 23, 'prenatally'), ('UBERON_0001898', 'hypothalamus', 71, 'hypothalamic'), ('UBERON_0002109', 'pair of nares', 84, 'pituitary'), ('UBERON_0002369', 'adrenal gland', 94, 'adrenal'), ('GO_0065007', 'biological regulation', 113, 'regulation'), ('CHEBI_17650', 'cortisol', 197, 'cortisol')]
PMC3574039	1/2013	S155-PMC3574039	['early Postnatal overnutrition, induced by small litter size [6,7,24,25,27,33], causes persistent hyperphagia and alters the Hypothalamic energy Homeostasis mechanism in Adulthood [2].']	N/A	N/A	[('GO_0007567', 'parturition', 6, 'postnatal'), ('UBERON_0001898', 'hypothalamus', 124, 'hypothalamic'), ('GO_0042592', 'homeostatic process', 144, 'homeostasis'), ('UBERON_0000113', 'post-juvenile adult stage', 169, 'adulthood')]
PMC3574039	1/2013	S156-PMC3574039	['the Hypothalamus is the primary center in the Brain that Regulates Food Intake and body Weight Homeostasis [34].']	N/A	N/A	[('UBERON_0001898', 'hypothalamus', 4, 'hypothalamus'), ('UBERON_0000955', 'brain', 46, 'brain'), ('GO_0065007', 'biological regulation', 57, 'regulates'), ('CHEBI_33290', 'food', 67, 'food'), ('GO_0007631', 'feeding behavior', 67, 'food intake'), ('GO_0001659', 'temperature homeostasis', 88, 'weight homeostasis')]
PMC3586494	2/2013	S148-PMC3586494	['the Hypothalamus has multiple Nerve Centers, or Nuclei, that are sensitive to a variety of physiologic changes.']	N/A	N/A	[('UBERON_0001898', 'hypothalamus', 4, 'hypothalamus'), ('UBERON_0002019', 'accessory XI nerve', 30, 'nerve centers'), ('UBERON_0000390', 'lens nucleus', 48, 'nuclei')]
PMC3608914	3/2013	S12-PMC3608914	['Pomc Neurons provide extensive Projections to various Parts of the Brain, especially to the Paraventricular (Pvh) and dorsomedial (dmh) Nuclei of the Hypothalamus, the Lateral Hypothalamic Area (Lha), and the Ventral Tegmental Area (Vta).']	N/A	N/A	[('PR_000013030', 'NADPH--cytochrome P450 reductase', 0, 'POMC'), ('CL_0000540', 'neuron', 5, 'neurons'), ('GO_0042995', 'cell projection', 31, 'projections'), ('UBERON_0001372', 'psoas minor muscle', 54, 'parts'), ('UBERON_0000955', 'brain', 67, 'brain'), ('UBERON_0002626', 'head of caudate nucleus', 92, 'paraventricular ...'), ('UBERON_0003123', 'pharyngeal arch artery 6', 109, 'PVH ...'), ('GO_0005634', 'nucleus', 136, 'nuclei'), ('UBERON_0001711', 'eyelid', 136, '... nuclei'), ('UBERON_0001898', 'hypothalamus', 150, 'hypothalamus'), ('UBERON_0002430', 'lateral hypothalamic area', 168, 'lateral hypothalamic area'), ('UBERON_0009856', 'sac', 195, 'LHA'), ('UBERON_0013179', 'posterior dorsal bursa', 209, 'ventral tegmental area'), ('UBERON_2005026', 'primary head sinus', 233, 'VTA')]
PMC3608914	3/2013	S15-PMC3608914	['pomc Neurons located in the Arcuate Nucleus Of the Hypothalamus (Arh) send direct Projections to discrete populations of Neurons located in the dorsomedial (dmh) and Paraventricular Nuclei (pvh) of the Hypothalamus and to the Lateral Hypothalamic Area (Lha).']	N/A	N/A	[('CL_0000540', 'neuron', 5, 'neurons'), ('UBERON_0001932', 'arcuate nucleus of hypothalamus', 28, 'arcuate nucleus of ... hypothalamus'), ('UBERON_0004360', 'cauda epididymis', 65, 'ARH'), ('GO_0042995', 'cell projection', 82, 'projections'), ('CL_0000540', 'neuron', 121, 'neurons'), ('UBERON_0004683', 'parasubiculum', 166, 'paraventricular'), ('UBERON_0000390', 'lens nucleus', 182, 'nuclei'), ('UBERON_0001898', 'hypothalamus', 202, 'hypothalamus'), ('UBERON_0002430', 'lateral hypothalamic area', 226, 'lateral hypothalamic area'), ('UBERON_0009856', 'sac', 253, 'LHA')]
PMC3608914	3/2013	S23-PMC3608914	['Mc4R mrna is found in virtually every part of the Brain, including the Hypothalamus, Thalamus, Cortex, Brainstem, and Spinal Cord (mountjoy et al.,1994; kishi et al.,2003).']	N/A	N/A	[('PR_000001244', 'long-wave-sensitive opsin 1', 0, 'MC4R'), ('UBERON_0000955', 'brain', 50, 'brain'), ('UBERON_0001898', 'hypothalamus', 71, 'hypothalamus'), ('UBERON_0001897', 'dorsal plus ventral thalamus', 85, 'thalamus'), ('UBERON_0001851', 'cortex', 95, 'cortex'), ('UBERON_0002298', 'brainstem', 103, 'brainstem'), ('UBERON_0002240', 'spinal cord', 118, 'spinal cord')]
PMC3608914	3/2013	S36-PMC3608914	['low levels of Pomc mrna are found in the Hypothalamus as early as Embryonic day (e)12, i.e., soon after the Birth of pomc Neurons.']	N/A	N/A	[('PR_000013508', 'PX domain-containing protein kinase-like protein', 14, 'Pomc'), ('UBERON_0001898', 'hypothalamus', 41, 'hypothalamus'), ('UBERON_0000922', 'embryo', 66, 'embryonic'), ('GO_0007567', 'parturition', 108, 'birth'), ('CL_0000540', 'neuron', 122, 'neurons')]
PMC3608914	3/2013	S39-PMC3608914	['mc4r mrna is also found in the Hypothalamus as early as on e12 and display a peak of Expression on e16.']	N/A	N/A	[('UBERON_0001898', 'hypothalamus', 31, 'hypothalamus'), ('GO_0010467', 'gene expression', 85, 'expression')]
PMC3608914	3/2013	S154-PMC3608914	['in addition, Rat neonates from protein-restricted dams display a reduction of Hypothalamic Dnmt1 and Dmnt3A mrna Expression (coupe et al.,2010).']	N/A	N/A	[('NCBITaxon_9986', 'Oryctolagus cuniculus', 13, 'rat'), ('UBERON_0001898', 'hypothalamus', 78, 'hypothalamic'), ('PR_000006543', 'doublesex- and mab-3-related transcription factor 2', 91, 'Dnmt1'), ('PR_000006564', 'dynein heavy chain 5, axonemal', 101, 'Dmnt3a'), ('GO_0010467', 'gene expression', 113, 'expression')]
PMC3640235	10/2012	S30-PMC3640235	['protein hormones\nprotein hormones are: Human Placental Lactogen (Hpl), Human Chorionic Gonadotropin (hcg), adrenocorticotropic (acth), growth hormone variant (hgh-v), Parathyroid Hormone-Related Protein (Pth-Rp), Calcitonin, relaxin, inhibins activins, atrial natriuretic peptide, Hypothalamic-like releasing and inhibiting hormones, thyrotropin releasing hormone (Trh), Gonadotropin Releasing Hormone (Gnrh), Corticotropin-releasing hormone (crh), somatostatin, Growth Hormone-releasing hormone (Ghrh), alpha fetoprotein, Prolactin, Relaxin and other Decidual proteins.']	N/A	N/A	[('NCBITaxon_10088', 'Mus <genus>', 39, 'Human'), ('PR_000008653', 'hepatocyte nuclear factor 1-beta', 39, 'Human'), ('CHEBI_81588', 'Placental lactogen', 45, 'placental lactogen'), ('PR_000012764', 'piwi-like protein 3', 45, 'placental lactogen'), ('UBERON_0001987', 'placenta', 45, 'placental'), ('PR_000008800', 'heat shock protein HSP 90-beta', 65, 'hPL'), ('NCBITaxon_10088', 'Mus <genus>', 71, 'Human'), ('UBERON_0003124', 'chorion', 77, 'chorionic'), ('PR_000001220', 'encephalopsin', 87, 'gonadotropin'), ('PR_000013535', 'putative 2-oxo-4-hydroxy-4-carboxy-5-ureidoimidazoline decarboxylase', 167, 'Parathyroid hormone-related protein'), ('UBERON_0001132', 'parathyroid gland', 167, 'Parathyroid'), ('PR_000013475', 'receptor-type tyrosine-protein phosphatase N2', 204, 'PTH-rP'), ('CHEBI_17793', 'calycosin', 213, 'Calcitonin'), ('UBERON_0001898', 'hypothalamus', 281, 'Hypothalamic'), ('PR_000016719', 'tumor susceptibility gene 101 protein', 365, 'TRH'), ('PR_000007939', 'glial fibrillary acidic protein', 371, 'Gonadotropin releasing hormone'), ('PR_000008293', 'glutathione synthetase', 403, 'GnRH'), ('CHEBI_3898', 'Cortol', 410, 'Corticotropin'), ('PR_000006009', 'alpha-catulin', 410, 'Corticotropin'), ('PR_000008294', 'glutathione S-transferase A1', 463, 'Growth hormone'), ('PR_000007964', 'glutathione hydrolase 6', 497, 'GHRH'), ('PR_000013504', 'periodic tryptophan protein 1', 523, 'prolactin'), ('PR_000014009', 'regulating synaptic membrane exocytosis protein 1', 534, 'relaxin'), ('UBERON_0002450', 'decidua', 552, 'decidual')]
PMC3669365	5/2013	S79-PMC3669365	['coronal Brain sections were divided into fractions of Hypothalamus, Cerebral Cortex, hippocampus, and Striatum by a Brain matrix.']	N/A	N/A	[('UBERON_0000955', 'brain', 8, 'brain'), ('UBERON_0001898', 'hypothalamus', 54, 'hypothalamus'), ('UBERON_0000956', 'cerebral cortex', 68, 'cerebral cortex'), ('UBERON_0002435', 'striatum', 102, 'striatum'), ('UBERON_0000955', 'brain', 116, 'brain')]
PMC3669365	5/2013	S157-PMC3669365	['in the Hypothalamus, dr Mice showed a small but significant increase in pparα and Brain-Specific Carnitine Palmitoyltransferase 1 (Cpt1C, encoded by cpt1c ) mrna Expression (figure 6i).']	N/A	N/A	[('UBERON_0001898', 'hypothalamus', 7, 'hypothalamus'), ('NCBITaxon_10088', 'Mus <genus>', 24, 'mice'), ('PR_000004593', 'N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase 3', 82, 'brain-specific carnitine palmitoyltransferase 1'), ('UBERON_0000955', 'brain', 82, 'brain'), ('CHEBI_17126', 'carnitine', 97, 'carnitine'), ('PR_000005800', 'carboxypeptidase A6', 131, 'CPT1C'), ('GO_0010467', 'gene expression', 162, 'expression')]
PMC3669365	5/2013	S158-PMC3669365	['regarding Feeding-related neuropeptides, no significant differences were observed in the Expression of Neuropeptide Y (Npy, encoded by Npy ), Agouti-Related Protein (Agrp, encoded by agrp ), Pro-Opiomelanocortin-Alpha (Pomc1, encoded by Pomc1 ), and Prepro-Orexin (Ox, encoded by ppox ) mrnas in the Hypothalamus (figure s7a).']	N/A	N/A	[('GO_0007631', 'feeding behavior', 10, 'feeding'), ('GO_0010467', 'gene expression', 89, 'expression'), ('PR_000011469', 'high affinity nerve growth factor receptor', 103, 'neuropeptide Y'), ('PR_000011368', 'N-acetylneuraminate lyase', 119, 'NPY'), ('PR_000011509', 'nuclear pore complex protein Nup155', 135, 'Npy'), ('PR_000003680', 'actin, cytoplasmic 2', 142, 'agouti-related protein'), ('PR_000003880', 'GTP:AMP phosphotransferase, mitochondrial', 166, 'AGRP'), ('PR_000013354', 'pregnancy-specific beta-1-glycoprotein 6', 191, 'pro-opiomelanocortin-alpha'), ('PR_000012980', 'DNA polymerase nu', 219, 'POMC1'), ('PR_000013039', 'POU domain, class 3, transcription factor 2', 237, 'Pomc1'), ('PR_000013043', 'POU domain, class 4, transcription factor 3', 250, 'prepro-orexin'), ('PR_000012086', 'homeobox protein OTX2', 265, 'OX'), ('UBERON_0001898', 'hypothalamus', 300, 'hypothalamus')]
PMC3669365	5/2013	S159-PMC3669365	['also, there were no significant differences in the mrna Expression of various Glucose Metabolism-related enzymes, transporters, or receptors in the Hypothalamus (figure s7b).10.1371/journal.pone.0064263.g006\n\ncaption (fig): figure 6\nMetabolic state in Adulthood (8–9 weeks).']	N/A	N/A	[('GO_0010467', 'gene expression', 56, 'expression'), ('CHEBI_17234', 'glucose', 78, 'glucose'), ('GO_0006006', 'glucose metabolic process', 78, 'glucose metabolism'), ('UBERON_0001898', 'hypothalamus', 148, 'hypothalamus'), ('GO_0008152', 'metabolic process', 233, 'Metabolic'), ('UBERON_0000113', 'post-juvenile adult stage', 252, 'adulthood')]
PMC3669365	5/2013	S167-PMC3669365	['protein levels of Ampkα and phosphorylated Ampkα (p-Ampkα), and their ratio (pampkα/Ampkα) in Hypothalamus and Cortex were not significantly different between the two groups (figure s8a–h).']	N/A	N/A	[('PR_000004510', 'ataxin-7-like protein 2', 18, 'AMPKα'), ('PR_000004510', 'ataxin-7-like protein 2', 43, 'AMPKα'), ('PR_000004510', 'ataxin-7-like protein 2', 52, 'AMPKα'), ('PR_000004510', 'ataxin-7-like protein 2', 84, 'AMPKα'), ('UBERON_0001898', 'hypothalamus', 94, 'hypothalamus'), ('UBERON_0001851', 'cortex', 111, 'cortex')]
PMC3669365	5/2013	S173-PMC3669365	['there were also no significant changes in Adenosine A1 Receptor (Adora1, encoded by adora1 ), Adenosine A2A Receptor (Adora2, encoded by adora2 ), adenosine kinase (Adk, encoded by Adk ), or adenosine deaminase (ada, encoded by Ada ) mrna Expression in either Hypothalamus or Cortex (figure 7d, e).10.1371/journal.pone.0064263.g007\n\ncaption (fig): figure 7\nadenosinergic system responsiveness in Adult offspring Mice.']	N/A	N/A	[('PR_000001188', 'alpha-2C adrenergic receptor', 42, 'adenosine A1 receptor'), ('PR_000001682', 'vasopressin V1b receptor', 65, 'ADORA1'), ('PR_000001188', 'alpha-2C adrenergic receptor', 94, 'adenosine A2a receptor'), ('PR_000001682', 'vasopressin V1b receptor', 118, 'ADORA2'), ('PR_000003790', 'ADP-ribose glycohydrolase ARH3', 165, 'ADK'), ('PR_000003920', 'retinal dehydrogenase 1', 181, 'Adk'), ('PR_000003790', 'ADP-ribose glycohydrolase ARH3', 228, 'Ada'), ('GO_0010467', 'gene expression', 239, 'expression'), ('UBERON_0001898', 'hypothalamus', 260, 'hypothalamus'), ('UBERON_0001851', 'cortex', 276, 'cortex'), ('UBERON_0007023', 'adult organism', 396, 'adult'), ('NCBITaxon_10088', 'Mus <genus>', 412, 'mice')]
PMC3669365	5/2013	S192-PMC3669365	['at 8–9 weeks old, the dr Adult offspring Mice showed small but significant increases in the mrna Expression of pparα and cpt1c in the Hypothalamus.']	N/A	N/A	[('UBERON_0007023', 'adult organism', 25, 'adult'), ('NCBITaxon_10088', 'Mus <genus>', 41, 'mice'), ('GO_0010467', 'gene expression', 97, 'expression'), ('UBERON_0001898', 'hypothalamus', 134, 'hypothalamus')]
PMC3669365	5/2013	S274-PMC3669365	['caption (supplementary-material): figure s7\n\nGene Expression related to the Feeding Regulation (a) and the Regulation Of Glucose Metabolism (b) such as hexokinase 1 (Hk1, encoded by Hk1 ), Hexokinase 2 (Hk2, encoded by Hk2 ), Phosphofructokinase, Muscle (Pfkm, encoded by Pfkm ), solute carrier family 2, Member 1 (Slc2A1, encoded by slc2a1 ), Solute Carrier Family 2, Member 3 (Slc2A3, encoded by slc2a3 ), Lactate dehydrogenase a (ldha, encoded by Ldha ), and Lactate dehydrogenase b (Ldhb, encoded by Ldhb ) in the Hypothalamus.']	N/A	N/A	[('GO_0010467', 'gene expression', 45, 'Gene expression'), ('SO_0000704', 'gene', 45, 'Gene'), ('GO_0007631', 'feeding behavior', 76, 'feeding'), ('GO_0065007', 'biological regulation', 84, 'regulation'), ('GO_0010906', 'regulation of glucose metabolic process', 107, 'regulation of glucose metabolism'), ('CHEBI_17234', 'glucose', 121, 'glucose'), ('PR_000003770', 'all-trans-retinol dehydrogenase [NAD(+)] ADH4', 163, '1'), ('PR_000008608', 'hexokinase-1', 166, 'HK1'), ('PR_000008608', 'hexokinase-1', 182, 'Hk1'), ('PR_000008609', 'hexokinase-2', 189, 'hexokinase 2'), ('PR_000008608', 'hexokinase-1', 203, 'HK2'), ('PR_000008608', 'hexokinase-1', 219, 'Hk2'), ('PR_000012582', 'ATP-dependent 6-phosphofructokinase, liver type', 226, 'phosphofructokinase, muscle'), ('PR_000012572', 'prefoldin subunit 1', 255, 'PFKM'), ('PR_000012774', 'polycystic kidney disease 2-like 1 protein', 272, 'Pfkm'), ('PR_000010283', 'mediator of RNA polymerase II transcription subunit 12-like protein', 302, '2, member 1'), ('PR_000015219', 'sodium/hydrogen exchanger 7', 315, 'SLC2A1'), ('PR_000015229', 'solute carrier organic anion transporter family member 4A1', 344, 'solute carrier family 2, member 3'), ('PR_000015199', 'cationic amino acid transporter 3', 379, 'SLC2A3'), ('CHEBI_24996', 'lactate', 408, 'lactate'), ('PR_000009751', 'lymphoid enhancer-binding factor 1', 450, 'Ldha'), ('CHEBI_24996', 'lactate', 462, 'lactate'), ('PR_000009751', 'lymphoid enhancer-binding factor 1', 487, 'LDHB'), ('PR_000009651', 'laminin subunit alpha-2', 504, 'Ldhb'), ('UBERON_0001898', 'hypothalamus', 518, 'hypothalamus')]
PMC3669365	5/2013	S279-PMC3669365	['caption (supplementary-material): figure s8\n\nthe protein levels of Ampkα, p-Ampkα, and p-Ampkα/Ampkα ratio in the Hypothalamus (a–d) and Cortex (e–h).']	N/A	N/A	[('PR_000004510', 'ataxin-7-like protein 2', 67, 'AMPKα'), ('PR_000004510', 'ataxin-7-like protein 2', 76, 'AMPKα'), ('PR_000004510', 'ataxin-7-like protein 2', 89, 'AMPKα'), ('PR_000004510', 'ataxin-7-like protein 2', 95, 'AMPKα'), ('UBERON_0001898', 'hypothalamus', 114, 'hypothalamus'), ('UBERON_0001851', 'cortex', 137, 'cortex')]
PMC3683620	5/2013	S3-PMC3683620	['in this review i will discuss the Perinatal Programming of Adult Hypothalamic stress and Feeding circuitry.']	N/A	N/A	[('GO_0036268', 'swimming', 34, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 34, 'perinatal'), ('GO_0007565', 'female pregnancy', 44, 'programming'), ('UBERON_0007023', 'adult organism', 59, 'adult'), ('UBERON_0001898', 'hypothalamus', 65, 'hypothalamic'), ('GO_0007631', 'feeding behavior', 89, 'feeding')]
PMC3683620	5/2013	S173-PMC3683620	['caption (fig): figure 2\n\nleptin, Insulin, and Glucocorticoids Modulate Hypothalamic connectivity during development .']	N/A	N/A	[('PR_000045358', 'insulin family protein', 33, 'insulin'), ('CHEBI_36597', 'phthalazine', 46, 'glucocorticoids'), ('GO_0065007', 'biological regulation', 62, 'modulate'), ('UBERON_0001898', 'hypothalamus', 71, 'hypothalamic')]
PMC3683620	5/2013	S177-PMC3683620	['from Birth in rodents and from approximately Gestational day 21 in Humans, the Hypothalamic pathways subserving Feeding start to fully mature (koutcherov et al.,2002; bouret and simerly,2006).']	N/A	N/A	[('GO_0007567', 'parturition', 5, 'birth'), ('GO_0007565', 'female pregnancy', 45, 'gestational'), ('NCBITaxon_9606', 'Homo sapiens', 67, 'humans'), ('UBERON_0001898', 'hypothalamus', 79, 'hypothalamic'), ('GO_0007631', 'feeding behavior', 112, 'feeding')]
PMC3683620	5/2013	S178-PMC3683620	['in rodents, connectivity between the Arc and the dorsomedial Hypothalamus (dmh) are established by Postnatal day (p) 6, the Arc and Pvn by p8-p10, and the Arc and Lateral Hypothalamus (Lh) by p12 (bouret et al.,2004a,b).']	N/A	N/A	[('UBERON_0004356', 'apical ectodermal ridge', 37, 'ARC'), ('UBERON_0001898', 'hypothalamus', 61, 'hypothalamus'), ('GO_0007567', 'parturition', 99, 'postnatal'), ('UBERON_0004356', 'apical ectodermal ridge', 124, 'ARC'), ('UBERON_0009910', 'posterior lateral plate mesoderm', 132, 'PVN'), ('UBERON_0004356', 'apical ectodermal ridge', 155, 'ARC'), ('UBERON_0002736', 'lateral nuclear group of thalamus', 163, 'lateral hypothalamus'), ('UBERON_0004621', 'lumbar vertebra 5', 185, 'LH')]
PMC3683620	5/2013	S201-PMC3683620	['Insulin usually acts to suppress Appetite via its actions at the Hypothalamus and suppresses Dopamine-mediated reward at the Ventral Tegmental Area (figlewicz et al.,2008).']	N/A	N/A	[('PR_000045358', 'insulin family protein', 0, 'Insulin'), ('GO_0000239', 'pachytene', 33, 'appetite'), ('UBERON_0001898', 'hypothalamus', 65, 'hypothalamus'), ('CHEBI_18243', 'dopamine', 93, 'dopamine'), ('UBERON_0013179', 'posterior dorsal bursa', 125, 'ventral tegmental area')]
PMC3700139	2/2011	S48-PMC3700139	['exposure to hfd during Gestation stimulates the Proliferation Of Neuronal and Neuroepithelial Cells of the Embryonic third ventricle of the hypothalamus and increases their migration to Hypothalamic regions resulting in an increase in the proportion of Neurons Expressing Orexigenic peptides [32].']	N/A	N/A	[('GO_0007565', 'female pregnancy', 23, 'gestation'), ('GO_0008283', 'cell proliferation', 48, 'proliferation of ... cells'), ('CL_0000540', 'neuron', 65, 'neuronal ...'), ('CL_0000513', 'cardiac muscle myoblast', 78, 'neuroepithelial cells'), ('UBERON_0000922', 'embryo', 107, 'embryonic'), ('UBERON_0001898', 'hypothalamus', 186, 'hypothalamic'), ('CL_0000540', 'neuron', 253, 'neurons'), ('GO_0010467', 'gene expression', 261, 'expressing'), ('GO_0042476', 'odontogenesis', 272, 'orexigenic')]
PMC3700139	2/2011	S94-PMC3700139	['administering Insulin to Rats during the last term of Gestation produces obesity in the offspring [6,56] and administering Insulin to the Hypothalamus of Rat pups during the time that projects from the arh to the pvh results in elevations in body weight, Insulin level, impaired Glucose tolerance, and increased vulnerability to diabetes [57].']	N/A	N/A	[('CHEBI_66075', 'inflexin', 14, 'insulin'), ('PR_000045358', 'insulin family protein', 14, 'insulin'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 25, 'rats'), ('GO_0007565', 'female pregnancy', 54, 'gestation'), ('PR_000045358', 'insulin family protein', 123, 'insulin'), ('UBERON_0001898', 'hypothalamus', 138, 'hypothalamus'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 154, 'rat'), ('PR_000045358', 'insulin family protein', 255, 'insulin'), ('CHEBI_17234', 'glucose', 279, 'glucose')]
PMC3705146	5/2013	S175-PMC3705146	['photoperiod is sensed via Projections along the Retino-Hypothalamic pathway to the Pineal Gland, operating as a step function (prendergast and zucker,2012).']	N/A	N/A	[('GO_0042995', 'cell projection', 26, 'projections'), ('UBERON_0000966', 'retina', 48, 'retino'), ('UBERON_0001898', 'hypothalamus', 55, 'hypothalamic'), ('UBERON_0001905', 'pineal body', 83, 'pineal gland')]
PMC3705146	5/2013	S183-PMC3705146	['a short photoperiod upregulates Hypothalamic Dopaminergic activity, inhibiting Prolactin Release and initiating the development Of a winter Coat.']	N/A	N/A	[('UBERON_0001898', 'hypothalamus', 32, 'hypothalamic'), ('CHEBI_18243', 'dopamine', 45, 'dopaminergic'), ('GO_0007341', 'penetration of zona pellucida', 79, 'prolactin release'), ('GO_0007608', 'sensory perception of smell', 128, 'of ...'), ('GO_0050890', 'cognition', 140, 'coat'), ('UBERON_0010166', 'coat of hair', 140, 'coat')]
PMC3781185	7/2013	S23-PMC3781185	['on the epigenetic plasticity of the Rat Hypothalamus (pp.']	N/A	N/A	[('NCBITaxon_10088', 'Mus <genus>', 36, 'Rat'), ('UBERON_0001898', 'hypothalamus', 40, 'Hypothalamus')]
PMC3828638	11/2013	S129-PMC3828638	['Food deprivation decreases Hypothalamic Crh mrna Expression in several Animal species (brady et al.,1990; glowa et al.,1992).']	N/A	N/A	[('CHEBI_33290', 'food', 0, 'Food'), ('UBERON_0001898', 'hypothalamus', 27, 'hypothalamic'), ('PR_000005864', 'protein CREG2', 40, 'CRH'), ('GO_0010467', 'gene expression', 49, 'expression'), ('NCBITaxon_33208', 'Metazoa', 71, 'animal')]
PMC3828638	11/2013	S172-PMC3828638	['in Rats and Mice, there is a surge in Plasma leptin concentration during Postnatal days (pnd) 4–12 (ahima et al.,1998; delahaye et al.,2008; cottrell et al.,2009), the time when connections between Hypothalamic Neurons are developing and leptin has no effect on Appetite (ahima and flier,2000).']	N/A	N/A	[('NCBITaxon_9986', 'Oryctolagus cuniculus', 3, 'rats'), ('NCBITaxon_10088', 'Mus <genus>', 12, 'mice'), ('UBERON_0001969', 'blood plasma', 38, 'plasma'), ('GO_0007567', 'parturition', 73, 'postnatal'), ('CL_0000743', 'hypertrophic chondrocyte', 198, 'hypothalamic neurons'), ('UBERON_0001898', 'hypothalamus', 198, 'hypothalamic'), ('GO_0000239', 'pachytene', 262, 'appetite')]
PMC3828638	11/2013	S173-PMC3828638	['rodents exposed to reduced Nutrient availability have reduced circulating leptin concentrations and increased Hypothalamic lepr protein Expression at Birth (cottrell et al.,2010; coupe et al.,2010), as well as a delayed and/or reduced leptin surge, which results in permanent changes in Hypothalamic Ingestive Behavior Regulatory circuits (gluckman et al.,2005; bautista et al.,2008).']	N/A	N/A	[('CHEBI_33284', 'nutrient', 27, 'nutrient'), ('UBERON_0001898', 'hypothalamus', 110, 'hypothalamic'), ('GO_0010467', 'gene expression', 136, 'expression'), ('GO_0007567', 'parturition', 150, 'birth'), ('UBERON_0001898', 'hypothalamus', 287, 'hypothalamic'), ('GO_0060817', 'inactivation of paternal X chromosome', 300, 'ingestive behavior regulatory')]
PMC3828638	11/2013	S177-PMC3828638	['reduced Gestational Nutrient availability permanently impairs the development and connectivity of Hypothalamic Neurons that produce anorectic neuropeptides such as α-msh and orexigenic neuropeptides such as Npy and agrp from weaning through Adulthood (muhlhausler et al.,2006; delahaye et al.,2008; coupe et al.,2010).']	N/A	N/A	[('GO_0007565', 'female pregnancy', 8, 'gestational'), ('CHEBI_33284', 'nutrient', 20, 'nutrient'), ('CL_0000743', 'hypertrophic chondrocyte', 98, 'hypothalamic neurons'), ('UBERON_0001898', 'hypothalamus', 98, 'hypothalamic'), ('PR_000011368', 'N-acetylneuraminate lyase', 207, 'NPY'), ('UBERON_0000113', 'post-juvenile adult stage', 241, 'adulthood')]
PMC3850030	9/2013	S469-PMC3850030	['abbreviations\na-dmrs: chronological age; aeds: Antiepileptic Drugs; afc: antral follicle count; amh: antimullerian hormone; apap: Acetaminophen (Paracetamol); ap-dmrs: age-related phenotypes; ar: Androgen receptor; Bm: Bone Marrow; Bpa: Bisphenol A; ccrk: Cell Cycle-related kinase; cdc: centers for disease control; Cns: Central Nervous System; cpgs: Cytosine-phosphate-guanine; ct: computerized tomography; Cxcr4+: C-x-C Chemokine Receptor Type 4; dmrs: differentially methylated regions; edstac: endocrine disruptor screening and testing advisory committee; facs: fluorescence activated cell sorting; fda: Food and Drug administration; Dha: Docosahexaenoic Acid; dna: Deoxyribonucleic Acid; dsm: diagnostic and statistical manual of mental disorders; Edcs: Endocrine-disrupting chemicals; ets: environmental tobacco smoke; f1-cd: control diet; f1-lpd: low-protein-diet; ffq: Food frequency questionnaire; fmri: functional magnetic resonance imaging; gh/igh: Growth Hormone/Insulin-Like Growth Factor 1; gr: glucocorticoid receptor; Hat: Histone Acetylases; hcc: hepatocellular carcinoma; hdac: Histone deacetylases; hfd: high-fat-diet; hpaa: Hypothalamic-Pituitary-Adrenal axis; Hsc: Hematopoietic Stem Cells; ictp: trimeric carboxyterminal telopeptide; infanib: infant Neurological international battery; iq: intelligence quotient; lbw: low-birthweight; lt-hsc: Long-Term Repopulation Of Hematopoietic Stem Cells; lys: lysine; Mgso4: Magnesium Sulfate; Mirna: micro-Ribonucleic Acid; mri: magnetic resonance imaging; Nac: N-Acetylcysteine; nhanes: national health and nutritional examination survey; nhis: national health interview survey; oc: Osteocalcin; O-Glcnac: O-Glcnacylation; ogtt: oral Glucose tolerance test; or: odds ratio; otc: over the counter; pbdes: polybrominated diphenyl ethers; pcos: polycystic Ovary syndrome; pet: positron emission tomography; pfcs: Perfluorinated Compounds; pp: precocious pubarche; psa: Prostate Specific Antigen; rna: Ribonucleic Acid; rt-pcr: reverse transcriptase polymerase chain reaction; scls: Salivary Cotinine levels; Sdf-1: Stromal-Cell-Derived-Factor-1; ses: socio-economic status; Sirnas: short inhibitory ribonucleic Acids; tcf: T-Cell factor; tcscs: Tissue-committed Stem Cells; tedx: the Endocrine disruption exchange; uspstf: u.s. preventive services task force; Vcam-1: Vascular Cell Adhesion Protein 1.']	N/A	N/A	[('CHEBI_35218', 'anthocyanin cation', 47, 'Antiepileptic drugs'), ('CHEBI_2404', 'acetosyringone', 130, 'Acetaminophen'), ('CHEBI_46195', 'paracetamol', 145, 'paracetamol'), ('CHEBI_50113', 'androgen', 196, 'Androgen'), ('UBERON_0005401', 'cerebral hemisphere gray matter', 215, 'BM'), ('UBERON_0002371', 'bone marrow', 219, 'Bone marrow'), ('CHEBI_34018', '(S)-AMPA', 232, 'BPA'), ('CHEBI_33216', 'bisphenol A', 237, 'Bisphenol A'), ('GO_0007049', 'cell cycle', 256, 'Cell cycle'), ('UBERON_0001017', 'central nervous system', 317, 'CNS'), ('UBERON_0001017', 'central nervous system', 322, 'Central nervous system'), ('CHEBI_4056', 'cytochrome', 352, 'Cytosine'), ('PR_000001209', 'C-X-C chemokine receptor type 5', 409, 'CXCR4'), ('CHEBI_51686', 'haematoxylin', 417, 'C-'), ('PR_000005920', 'lambda-crystallin', 417, 'C-'), ('PR_000001215', 'atypical chemokine receptor 2', 420, '-C chemokine receptor type 4'), ('CHEBI_33290', 'food', 609, 'Food'), ('CHEBI_23888', 'drug', 618, 'Drug'), ('CHEBI_17874', 'dihydrozeatin', 639, 'DHA'), ('CHEBI_78869', 'octacosapentaenoic acid', 644, 'Docosahexaenoic acid'), ('CHEBI_86026', 'tRNA threonylcarbamoyladenosine', 671, 'Deoxyribonucleic acid'), ('CL_0002364', 'cortical thymic epithelial cell', 754, 'EDCs'), ('GO_0009790', 'embryo development', 760, 'Endocrine'), ('CHEBI_33290', 'food', 878, 'Food'), ('CHEBI_5542', 'grayanotoxin I', 961, 'Growth Hormone'), ('PR_000008959', 'immunoglobulin heavy constant gamma 1', 976, 'Insulin-like growth factor 1'), ('PR_000008443', 'huntingtin-associated protein 1', 1035, 'HAT'), ('CHEBI_15358', 'histone', 1040, 'Histone'), ('PR_000008454', 'hepatitis A virus cellular receptor 2', 1040, 'Histone acetylases'), ('CHEBI_15358', 'histone', 1097, 'Histone'), ('PR_000027594', 'histone H3', 1097, 'Histone'), ('UBERON_0001898', 'hypothalamus', 1145, 'Hypothalamic'), ('UBERON_0002109', 'pair of nares', 1158, 'pituitary'), ('UBERON_0002369', 'adrenal gland', 1168, 'adrenal'), ('CL_0000037', 'hematopoietic stem cell', 1182, 'HSC'), ('CL_0000037', 'hematopoietic stem cell', 1187, 'Hematopoietic stem cells'), ('GO_0030097', 'hemopoiesis', 1187, 'Hematopoietic'), ('UBERON_0001016', 'nervous system', 1273, 'Neurological'), ('GO_0006099', 'tricarboxylic acid cycle', 1366, 'Long-term'), ('GO_0009450', 'gamma-aminobutyric acid catabolic process', 1376, 'repopulation of'), ('CL_0000037', 'hematopoietic stem cell', 1392, 'hematopoietic stem cells'), ('GO_0016476', 'regulation of embryonic cell shape', 1392, 'hematopoietic stem cells'), ('CHEBI_32599', 'magnesium sulfate', 1431, 'MgSO4'), ('CHEBI_31795', 'magnesium sulfate heptahydrate', 1438, 'Magnesium sulfate'), ('SO_0000276', 'miRNA', 1457, 'miRNA'), ('CHEBI_15986', 'polynucleotide', 1470, 'ribonucleic acid'), ('CHEBI_7421', 'NAC', 1521, 'NAC'), ('CHEBI_70981', '6-formylpterin', 1526, 'N-acetylcysteine'), ('PR_000011634', 'oxidized low-density lipoprotein receptor 1', 1648, 'Osteocalcin'), ('CHEBI_63103', 'NSDB 211', 1661, 'O-GlcNAc'), ('CHEBI_52846', 'cycloalkane ring', 1671, 'O-GlcNAcylation'), ('CHEBI_17234', 'glucose', 1699, 'glucose'), ('UBERON_0000992', 'ovary', 1818, 'ovary'), ('CHEBI_86922', 'Pinoresinol biphenyl', 1875, 'Perfluorinated'), ('CHEBI_36357', 'polyatomic entity', 1890, 'compounds'), ('PR_000001908', 'platelet glycoprotein Ib beta chain', 1931, 'Prostate specific antigen'), ('CHEBI_59132', 'antigen', 1949, 'antigen'), ('CHEBI_15986', 'polynucleotide', 1963, 'Ribonucleic acid'), ('UBERON_0001836', 'saliva', 2044, 'Salivary'), ('CHEBI_18123', 'N-methylnicotinate', 2053, 'cotinine'), ('PR_000014762', 'serine/arginine-rich splicing factor 5', 2070, 'SDF-1'), ('CL_0000810', 'CD4-positive, alpha-beta thymocyte', 2077, 'Stromal-cell'), ('PR_000015629', 'SRSF protein kinase 1', 2077, 'Stromal-cell-derived-factor-1'), ('UBERON_0003891', 'stroma', 2077, 'Stromal'), ('SO_0000646', 'siRNA', 2136, 'siRNAs'), ('CHEBI_37527', 'acid', 2173, 'acids'), ('CL_0000084', 'T cell', 2185, 'T-cell'), ('CL_0000895', 'naive thymus-derived CD4-positive, alpha-beta T cell', 2207, 'Tissue ...'), ('UBERON_0000479', 'tissue', 2207, 'Tissue'), ('CL_0000034', 'stem cell', 2224, 'stem cells'), ('GO_0009790', 'embryo development', 2246, 'Endocrine'), ('PR_000001970', 'vascular cell adhesion protein 1', 2322, 'VCAM-1'), ('CL_0000635', "Deiter's cell", 2330, 'Vascular cell'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 2330, 'Vascular cell adhesion protein 1')]
PMC3907150	1/2014	S231-PMC3907150	['in the Hypothalamus, the Corticotropin-Releasing Factor Promoter had reduced levels of Dna Methylation and the Glucocorticoid receptor Promoter had increased methylation; additionally, the Corticotropin-releasing factor Promoter in dna isolated from the central Nucleus of the Amygdala also had reduced methylation.']	N/A	N/A	[('UBERON_0001898', 'hypothalamus', 7, 'hypothalamus'), ('PR_000005890', 'crooked neck-like protein 1', 25, 'corticotropin-releasing factor'), ('SO_0000167', 'promoter', 56, 'promoter'), ('GO_0006306', 'DNA methylation', 87, 'DNA methylation'), ('CHEBI_24261', 'glucocorticoid', 111, 'glucocorticoid'), ('SO_0000167', 'promoter', 135, 'promoter'), ('PR_000005890', 'crooked neck-like protein 1', 189, 'corticotropin'), ('SO_0000167', 'promoter', 220, 'promoter'), ('GO_0005634', 'nucleus', 262, 'nucleus'), ('UBERON_0001876', 'amygdala', 277, 'amygdala')]
PMC3976831	3/2014	S102-PMC3976831	['in the Brain, the Pituitary is the site of action of administered Dexamethasone in the blockade of stress induced Hypothalamic-Pituitary axis (hpa) activation.']	N/A	N/A	[('UBERON_0000955', 'brain', 7, 'brain'), ('UBERON_0002109', 'pair of nares', 18, 'pituitary'), ('CHEBI_41879', 'dexamethasone', 66, 'dexamethasone'), ('UBERON_0001898', 'hypothalamus', 114, 'hypothalamic'), ('UBERON_0002109', 'pair of nares', 127, 'pituitary')]
PMC3996361	4/2014	S7-PMC3996361	['these include changes in Hypothalamic-Pituitary-Adrenal axis function, body composition, Glucose Metabolism, and Cardiovascular function.']	N/A	N/A	[('UBERON_0001898', 'hypothalamus', 25, 'hypothalamic'), ('UBERON_0002109', 'pair of nares', 38, 'pituitary'), ('UBERON_0002369', 'adrenal gland', 48, 'adrenal'), ('CHEBI_17234', 'glucose', 89, 'glucose'), ('GO_0006006', 'glucose metabolic process', 89, 'glucose metabolism'), ('UBERON_0004535', 'cardiovascular system', 113, 'cardiovascular')]
PMC4002571	12/2013	S0-PMC4002571	['Prenatal Nicotine exposure enhances the susceptibility to Metabolic syndrome in Adult offspring Rats Fed high-fat diet via alteration of hpa axis-associated neuroendocrine Metabolic programming\n\nabstract\n\naim:\nPrenatal Nicotine exposure (pne) alters the Hypothalamic-Pituitary-Adrenocortical (hpa) axis-associated Neuroendocrine Metabolic Programming in Intrauterine growth retardation offspring Rats.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 0, 'Prenatal'), ('CHEBI_25501', 'neoxanthin', 9, 'nicotine'), ('GO_0008152', 'metabolic process', 58, 'metabolic'), ('UBERON_0007023', 'adult organism', 80, 'adult'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 96, 'rats'), ('GO_0007631', 'feeding behavior', 101, 'fed'), ('GO_0008152', 'metabolic process', 172, 'metabolic'), ('GO_0007565', 'female pregnancy', 210, 'Prenatal'), ('CHEBI_25501', 'neoxanthin', 219, 'nicotine'), ('UBERON_0001898', 'hypothalamus', 254, 'hypothalamic'), ('UBERON_0002109', 'pair of nares', 267, 'pituitary'), ('UBERON_0001988', 'feces', 277, 'adrenocortical'), ('GO_0001843', 'neural tube closure', 314, 'neuroendocrine'), ('GO_0006402', 'mRNA catabolic process', 329, 'metabolic programming'), ('UBERON_0022293', 'reproductive gland secretion', 354, 'intrauterine'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 396, 'rats')]
PMC4002571	12/2013	S4-PMC4002571	['the Hypothalamus, Pituitary Gland and Liver were dissected for histological studies.']	N/A	N/A	[('UBERON_0001898', 'hypothalamus', 4, 'hypothalamus'), ('UBERON_0000007', 'pituitary gland', 18, 'pituitary gland'), ('UBERON_0002107', 'liver', 38, 'liver')]
PMC4002571	12/2013	S68-PMC4002571	['the Hypothalamus, Pituitary Gland and Liver were dissected and fixed in a 4% paraformaldehyde Solution for histological examination.']	N/A	N/A	[('UBERON_0001898', 'hypothalamus', 4, 'hypothalamus'), ('UBERON_0000007', 'pituitary gland', 18, 'pituitary gland'), ('UBERON_0002107', 'liver', 38, 'liver'), ('CHEBI_75958', 'solution', 94, 'solution')]
PMC4002571	12/2013	S74-PMC4002571	['histological examination\nthe Hypothalamus, Pituitary Gland and Liver were fixed in a 4% paraformaldehyde Solution overnight and processed using the paraffin section technique.']	N/A	N/A	[('UBERON_0001898', 'hypothalamus', 29, 'hypothalamus'), ('UBERON_0000007', 'pituitary gland', 43, 'pituitary gland'), ('UBERON_0002107', 'liver', 63, 'liver'), ('CHEBI_75958', 'solution', 105, 'solution')]
PMC4002571	12/2013	S101-PMC4002571	['pathological alterations\nthe normal architecture of the Hypothalamus, Pituitary Gland and Liver were observed in the male and female control Rats (figures 6a1–6a3and6c1–6c3).']	N/A	N/A	[('UBERON_0001898', 'hypothalamus', 56, 'hypothalamus'), ('UBERON_0000007', 'pituitary gland', 70, 'pituitary gland'), ('UBERON_0002107', 'liver', 90, 'liver'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 141, 'rats')]
PMC4026680	3/2014	S5-PMC4026680	['in the case of an acute stress that requires a physical response, such as a predator-prey interaction, this Hypothalamic-Pituitary-Adrenal (hpa) axis Modulation Of Food Intake allows the stressful event to be dealt with and the energy used to be replaced afterward.']	N/A	N/A	[('UBERON_0001898', 'hypothalamus', 108, 'hypothalamic'), ('UBERON_0002109', 'pair of nares', 121, 'pituitary'), ('UBERON_0002369', 'adrenal gland', 131, 'adrenal'), ('GO_0061724', 'lipophagy', 150, 'modulation of'), ('CHEBI_33290', 'food', 164, 'food'), ('GO_0007631', 'feeding behavior', 164, 'food intake')]
PMC4026680	3/2014	S39-PMC4026680	['in terms of Feeding behavior, Glucocorticoids also act on the Hypothalamus to stimulate Appetite (santana et al., 1995;dallman et al., 2004).']	N/A	N/A	[('GO_0007631', 'feeding behavior', 12, 'feeding'), ('CHEBI_36597', 'phthalazine', 30, 'glucocorticoids'), ('UBERON_0001898', 'hypothalamus', 62, 'hypothalamus'), ('GO_0000239', 'pachytene', 88, 'appetite')]
PMC4026680	3/2014	S47-PMC4026680	['Insulin usually acts at the Hypothalamus to reduce Food Intake and at the Ventral Tegmental Area (Vta) to reduce the Dopaminergic Neuron-mediated rewarding nature of Food (figlewicz et al., 2008).']	N/A	N/A	[('PR_000045358', 'insulin family protein', 0, 'Insulin'), ('UBERON_0001898', 'hypothalamus', 28, 'hypothalamus'), ('CHEBI_33290', 'food', 51, 'food'), ('GO_0007631', 'feeding behavior', 51, 'food intake'), ('UBERON_0013179', 'posterior dorsal bursa', 74, 'ventral tegmental area'), ('UBERON_2005026', 'primary head sinus', 98, 'VTA'), ('CHEBI_18243', 'dopamine', 117, 'dopaminergic'), ('CL_0000700', 'dopaminergic neuron', 117, 'dopaminergic neuron'), ('CHEBI_33290', 'food', 166, 'food')]
PMC4061886	7/2013	S156-PMC4061886	['indeed, pnee females exhibit an increased Hypothalamic-Pituitary-Adrenal (hpa) sensitivity to Estrogen, and Estrogen levels are higher during Proestrous in pnee females compared to controls [49].']	N/A	N/A	[('UBERON_0001898', 'hypothalamus', 42, 'hypothalamic'), ('UBERON_0002109', 'pair of nares', 55, 'pituitary'), ('UBERON_0002369', 'adrenal gland', 65, 'adrenal'), ('CHEBI_50114', 'estrogen', 94, 'estrogen'), ('CHEBI_50114', 'estrogen', 108, 'estrogen'), ('GO_0060208', 'proestrus', 142, 'proestrous')]
PMC4089555	5/2014	S59-PMC4089555	['tsh is synthesized and Secreted in response to Tsh releasing hormone (trh) from the Hypothalamus.']	N/A	N/A	[('GO_0046903', 'secretion', 23, 'secreted'), ('CHEBI_17855', 'triglyceride', 47, 'TSH'), ('UBERON_0001898', 'hypothalamus', 84, 'hypothalamus')]
PMC4129499	8/2014	S181-PMC4129499	['Antibodies in patients with autism are found to cells in the Caudate Nucleus (131), Cerebellum (132,133), Hypothalamus and Thalamus (121), the Cingulate Gyrus (134), and to Cerebral Folate receptors (135).']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 0, 'Antibodies'), ('UBERON_0002866', 'caudal part of spinal trigeminal nucleus', 61, 'caudate nucleus'), ('UBERON_0002037', 'cerebellum', 84, 'cerebellum'), ('UBERON_0001898', 'hypothalamus', 106, 'hypothalamus'), ('UBERON_0001897', 'dorsal plus ventral thalamus', 123, 'thalamus'), ('UBERON_0007841', 'furcula', 143, 'cingulate'), ('UBERON_0000200', 'gyrus', 153, 'gyrus'), ('UBERON_0001893', 'telencephalon', 173, 'cerebral'), ('CHEBI_30863', '5-azaorotic acid', 182, 'folate')]
PMC4183922	6/2014	S12-PMC4183922	['appropriate Nutrient and hormone exposure of the fetus in utero as well as during early Postnatal periods is key to healthy development and Regulation of these Hypothalamic pathways (9–11).']	N/A	N/A	[('CHEBI_33284', 'nutrient', 12, 'nutrient'), ('GO_0007567', 'parturition', 88, 'postnatal'), ('GO_0065007', 'biological regulation', 140, 'regulation'), ('UBERON_0001898', 'hypothalamus', 160, 'hypothalamic')]
PMC4183922	6/2014	S19-PMC4183922	['Hypothalamic Neurons are exquisitely sensitive to changes in Extracellular Glucose-levels (16) and disturbance of their ability to respond appropriately leads to dysfunctional maintenance of whole body Glucose Homeostasis (17).']	N/A	N/A	[('CL_0000743', 'hypertrophic chondrocyte', 0, 'Hypothalamic neurons'), ('UBERON_0001898', 'hypothalamus', 0, 'Hypothalamic'), ('GO_0005576', 'extracellular region', 61, 'extracellular'), ('CHEBI_17234', 'glucose', 75, 'glucose'), ('CHEBI_17234', 'glucose', 202, 'glucose'), ('GO_0042593', 'glucose homeostasis', 202, 'glucose homeostasis')]
PMC4183922	6/2014	S56-PMC4183922	['Glucose-sensitive Hypothalamic Gene Expression Modulation.']	N/A	N/A	[('CHEBI_17234', 'glucose', 0, 'Glucose'), ('UBERON_0001898', 'hypothalamus', 18, 'hypothalamic'), ('GO_0010468', 'regulation of gene expression', 31, 'gene expression modulation'), ('SO_0000704', 'gene', 31, 'gene')]
PMC4231349	10/2013	S156-PMC4231349	['the Hypothalamus as well as the Medulla were found to be relatively enlarged in the kd compared with the sd.']	N/A	N/A	[('UBERON_0001898', 'hypothalamus', 4, 'hypothalamus'), ('UBERON_0000958', 'medulla of organ', 32, 'medulla')]
PMC4231349	10/2013	S221-PMC4231349	['the kd Brain had a bilateral relative decrease in the Cortex, hippocampus, Corpus Callosum, fimbria, and Lateral Ventricles, but a relative enlargement in volume in the Hypothalamus and Medulla.']	N/A	N/A	[('UBERON_0000955', 'brain', 7, 'brain'), ('UBERON_0001851', 'cortex', 54, 'cortex'), ('UBERON_0002336', 'corpus callosum', 75, 'corpus callosum'), ('UBERON_0002285', 'telencephalic ventricle', 105, 'lateral ventricles'), ('UBERON_0001898', 'hypothalamus', 169, 'hypothalamus'), ('UBERON_0000958', 'medulla of organ', 186, 'medulla')]
PMC4264037	9/2014	S10-PMC4264037	['Neurogenesis and differentiation in the developing Hypothalamus\nNeural Tube Development can be divided into stages, the first of which is regionalization.']	N/A	N/A	[('GO_0001822', 'kidney development', 0, 'Neurogenesis'), ('UBERON_0001898', 'hypothalamus', 51, 'hypothalamus'), ('GO_0003172', 'sinoatrial valve development', 64, 'Neural tube development'), ('UBERON_0001049', 'neural tube', 64, 'Neural tube')]
PMC4264037	9/2014	S11-PMC4264037	['during the period prior to Embryonic day 10 (e10), the Diencephalic region is separated from surrounding regions by the influence of organizing signals such as Wingless/integrins (wnts), Sonic Hedgehog (Shh), Bone Morphogenetic Proteins (Bmps), and Fibroblast growth factors (fgfs), culminating ultimately in the induction of the Nk2 homeobox transcription factor Nkx2.1 — a key marker of Hypothalamic Tissue (for review, see ref.[2]).']	N/A	N/A	[('UBERON_0000922', 'embryo', 27, 'embryonic'), ('UBERON_0001603', 'lateral rectus extra-ocular muscle', 55, 'diencephalic'), ('PR_000017415', 'WASP-associated protein with actin, membranes and microtubules', 160, 'Wingless'), ('PR_000014841', 'sonic hedgehog protein', 187, 'Sonic hedgehog'), ('PR_000014841', 'sonic hedgehog protein', 203, 'Shh'), ('GO_0060349', 'bone morphogenesis', 209, 'Bone morphogenetic'), ('PR_000000035', 'BMP receptor type-1A', 209, 'Bone morphogenetic proteins'), ('PR_000000034', 'BMP', 238, 'Bmps'), ('CL_0000057', 'fibroblast', 249, 'fibroblast'), ('PR_000011242', 'homeobox protein Nkx-2.2', 330, 'NK2'), ('PR_000011159', 'nexilin', 364, 'Nkx2.1'), ('UBERON_0001898', 'hypothalamus', 389, 'hypothalamic'), ('UBERON_0000479', 'tissue', 402, 'tissue')]
PMC4264037	9/2014	S61-PMC4264037	['Mash1 is Expressed in the retrochiasmic Hypothalamic Basal Plate, as well as in the ventralmost regions of the nearby Alar Plate.']	N/A	N/A	[('PR_000010229', 'membrane-bound transcription factor site-1 protease', 0, 'Mash1'), ('GO_0010467', 'gene expression', 9, 'expressed'), ('UBERON_0001898', 'hypothalamus', 40, 'hypothalamic'), ('UBERON_0004064', 'neural tube basal plate', 53, 'basal plate'), ('UBERON_0005882', 'neural tube alar plate', 118, 'alar plate')]
PMC4264037	9/2014	S83-PMC4264037	['Mice possessing homozygous disruptions to the Sf1 Gene show massive hypocellularity in the vmh, with sparing of the other Hypothalamic Nuclei[40,41].']	N/A	N/A	[('NCBITaxon_10088', 'Mus <genus>', 0, 'Mice'), ('PR_000014841', 'sonic hedgehog protein', 46, 'Sf1'), ('SO_0000704', 'gene', 50, 'gene'), ('UBERON_0001898', 'hypothalamus', 122, 'hypothalamic'), ('UBERON_0000390', 'lens nucleus', 135, 'nuclei')]
PMC4264037	9/2014	S181-PMC4264037	['primary cultures derived from ed18 Mouse Hypothalamus do not show Stat3 phosphorylation upon leptin exposure, but do show decreased Npy and Pomc Expression[77].']	N/A	N/A	[('NCBITaxon_10088', 'Mus <genus>', 35, 'mouse'), ('UBERON_0001898', 'hypothalamus', 41, 'hypothalamus'), ('PR_000015700', 'alpha-2,8-sialyltransferase 8F', 66, 'STAT3'), ('PR_000011368', 'N-acetylneuraminate lyase', 132, 'NPY'), ('PR_000013030', 'NADPH--cytochrome P450 reductase', 140, 'POMC'), ('GO_0010467', 'gene expression', 145, 'expression')]
PMC4266867	11/2014	S108-PMC4266867	['in rodents, leptin stimulates gonadotropin secretion both at the Hypothalamic and the Pituitary level.']	N/A	N/A	[('UBERON_0001898', 'hypothalamus', 65, 'hypothalamic'), ('UBERON_0002109', 'pair of nares', 86, 'pituitary')]
PMC4292443	1/2015	S27-PMC4292443	['however, neonatal overfeeding also causes significant and substantial peripheral and central inflammation, including a pro-inflammatory profile in systemic Tissue and the Hypothalamus, as well as exacerbated pro-inflammatory response to a Neuroimmune challenge with bacterial mimetic Lipopolysaccharide (Lps) (tapia-gonzalez et al.,2011; clarke et al.,2012; ye et al.,2012; ziko et al.,2014).']	N/A	N/A	[('UBERON_0000479', 'tissue', 156, 'tissue'), ('UBERON_0001898', 'hypothalamus', 171, 'hypothalamus'), ('UBERON_0001049', 'neural tube', 239, 'neuroimmune'), ('CHEBI_16412', 'lipopolysaccharide', 284, 'lipopolysaccharide'), ('CHEBI_16412', 'lipopolysaccharide', 304, 'LPS')]
PMC4292443	1/2015	S197-PMC4292443	['caption (fig): figure 6\n\neffects of neonatal overfeeding on Hypothalamic Microglia after 3 day or 3 week high fat diet .']	N/A	N/A	[('CL_0002600', 'smooth muscle cell of trachea', 60, 'hypothalamic microglia'), ('UBERON_0001898', 'hypothalamus', 60, 'hypothalamic')]
PMC4311629	1/2015	S132-PMC4311629	['Bmp8B, another member of the Bmp family, was found to be Expressed in Bat, as well as in the Hypothalamus (contreras et al.,2014).']	N/A	N/A	[('PR_000000168', 'BMP7', 0, 'BMP8B'), ('PR_000000034', 'BMP', 29, 'BMP'), ('GO_0010467', 'gene expression', 57, 'expressed'), ('UBERON_0001348', 'brown adipose tissue', 70, 'BAT'), ('UBERON_0001898', 'hypothalamus', 93, 'hypothalamus')]
PMC4314535	10/2014	S21-PMC4314535	['the Rodent Hypothalamus develops primarily during the Postnatal period under the influence of intrinsic and environmental cues (see[13]for a review).']	N/A	N/A	[('NCBITaxon_33208', 'Metazoa', 4, 'rodent'), ('UBERON_0001898', 'hypothalamus', 11, 'hypothalamus'), ('GO_0007567', 'parturition', 54, 'postnatal')]
PMC4358872	2/2015	S141-PMC4358872	['furthermore, hypoxia inhibits Gh Release by enhancing the Expression of Somatostatin, the Hypothalamic gh Inhibitor [97].']	N/A	N/A	[('GO_0007173', 'epidermal growth factor receptor signaling pathway', 30, 'GH release'), ('GO_0010467', 'gene expression', 58, 'expression'), ('PR_000015900', 'putative synaptotagmin-14-like protein', 72, 'somatostatin'), ('UBERON_0001898', 'hypothalamus', 90, 'hypothalamic'), ('CHEBI_35222', 'inhibitor', 106, 'inhibitor')]
PMC4372177	2/2015	S176-PMC4372177	['these include leptin and related Genes lep , Lepr , Cnr1 , Drd2 , and Slc6A4 as well as the Hypothalamic factor Pomc and its processor Pcsk1 and neurotropic factor Bdnf and its receptor Ntrk2 [53].']	N/A	N/A	[('SO_0000704', 'gene', 33, 'genes'), ('PR_000009751', 'lymphoid enhancer-binding factor 1', 45, 'LEPR'), ('PR_000005169', 'CMRF35-like molecule 9', 52, 'CNR1'), ('PR_000001177', 'D(2) dopamine receptor', 59, 'DRD2'), ('PR_000015190', 'sodium- and chloride-dependent glycine transporter 2', 70, 'SLC6A4'), ('UBERON_0001898', 'hypothalamus', 92, 'hypothalamic'), ('PR_000013030', 'NADPH--cytochrome P450 reductase', 112, 'POMC'), ('PR_000012424', 'pecanex-like protein 1', 135, 'PCSK1'), ('PR_000004716', 'brain-derived neurotrophic factor', 164, 'BDNF'), ('PR_000011459', 'neurotrophin-3', 186, 'NTRK2')]
PMC4438628	5/2015	S60-PMC4438628	['they include those involving immuno-inflammatory (for example, elevations in C-Reactive Protein and inflammatory cytokines), Metabolic (for example, Insulin resistance, metabolic syndrome), the burden of oxidative stress, Hypothalamic-Pituitary-Adrenal (hpa) axis (for example, Cortisol perturbations), Neurotransmitter/neuropeptide (for example, Dopamine, Serotonin, Gamma-Aminobutyric Acid, Brain-Derived Neurotrophic Factor) communication, and other Systems [58,59].']	N/A	N/A	[('PR_000005890', 'crooked neck-like protein 1', 77, 'C-reactive protein'), ('GO_0008152', 'metabolic process', 125, 'metabolic'), ('PR_000045358', 'insulin family protein', 149, 'insulin'), ('UBERON_0001898', 'hypothalamus', 222, 'hypothalamic'), ('UBERON_0002109', 'pair of nares', 235, 'pituitary'), ('UBERON_0002369', 'adrenal gland', 245, 'adrenal'), ('CHEBI_17650', 'cortisol', 278, 'cortisol'), ('CHEBI_25512', 'neurotransmitter', 303, 'neurotransmitter'), ('CHEBI_18243', 'dopamine', 347, 'dopamine'), ('CHEBI_28790', 'serotonin', 357, 'serotonin'), ('CHEBI_16865', 'gamma-aminobutyric acid', 368, 'gamma-aminobutyric acid'), ('PR_000004732', 'bifunctional apoptosis regulator', 393, 'brain-derived neurotrophic factor'), ('UBERON_0000955', 'brain', 393, 'brain'), ('UBERON_0000467', 'anatomical system', 453, 'systems')]
PMC4476607	1/2015	S155-PMC4476607	['2012) and significantly attenuates Ethanol-induced hypermethylation of Genes in the Hypothalamus (bekdash et al.']	N/A	N/A	[('CHEBI_16236', 'ethanol', 35, 'ethanol'), ('SO_0000704', 'gene', 71, 'genes'), ('UBERON_0001898', 'hypothalamus', 84, 'hypothalamus')]
PMC4636015	9/2015	S158-PMC4636015	['Hypothalamus) (13).']	N/A	N/A	[('UBERON_0001898', 'hypothalamus', 0, 'hypothalamus')]
PMC4663588	11/2015	S146-PMC4663588	['moreover, Hypothalamic Gene Expression of Agouti Related Protein (Agrp) in offspring Born to dams on the Soy Protein-based diet was higher at weaning.']	N/A	N/A	[('UBERON_0001898', 'hypothalamus', 10, 'hypothalamic'), ('GO_0010467', 'gene expression', 23, 'gene expression'), ('SO_0000704', 'gene', 23, 'gene'), ('PR_000003890', 'A-kinase anchor protein 3', 42, 'agouti related protein'), ('PR_000003580', 'ABI gene family member 3', 66, 'AgRP'), ('GO_0007567', 'parturition', 85, 'born'), ('CHEBI_16095', 'sepiapterin', 105, 'soy protein')]
PMC4663588	11/2015	S279-PMC4663588	['the Hypothalamus is particularly sensitive to levels of circulatory hormones during the Prenatal period [116].']	N/A	N/A	[('UBERON_0001898', 'hypothalamus', 4, 'hypothalamus'), ('GO_0007565', 'female pregnancy', 88, 'prenatal')]
PMC4663588	11/2015	S280-PMC4663588	['increased Insulin concentration within the immature Hypothalamus leads to permanent dysplasia of Central Nervous Nuclei Regulating Metabolism and body weight in the Ventromedial Hypothalamic Nucleus (Vmn) [115,116,117,118,119].']	N/A	N/A	[('PR_000045358', 'insulin family protein', 10, 'insulin'), ('UBERON_0001898', 'hypothalamus', 52, 'hypothalamus'), ('UBERON_0002610', 'cochlear nuclear complex', 97, 'central nervous nuclei'), ('GO_0065007', 'biological regulation', 120, 'regulating'), ('GO_0008152', 'metabolic process', 131, 'metabolism'), ('UBERON_0001925', 'ventral lateral nucleus of thalamus', 165, 'ventromedial hypothalamic nucleus'), ('UBERON_0005414', 'zone of polarizing activity', 200, 'VMN')]
PMC4663588	11/2015	S282-PMC4663588	['neonatal Insulin treatment induces morphological alterations in Hypothalamic structures that leads to the development of obesity and Adult hyperinsulinemia in Rats [122].']	N/A	N/A	[('PR_000045358', 'insulin family protein', 9, 'insulin'), ('UBERON_0001898', 'hypothalamus', 64, 'hypothalamic'), ('UBERON_0007023', 'adult organism', 133, 'adult'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 159, 'rats')]
PMC4663588	11/2015	S290-PMC4663588	['offspring of Rats injected subcutaneously with leptin during the first ten days of Life have increased Food Intake, body weight and reduced responsiveness to leptin in later Life associated with lower levels of Obrb (a Leptin Receptor B Isoform) Expression in the Hypothalamus [129].']	N/A	N/A	[('NCBITaxon_9986', 'Oryctolagus cuniculus', 13, 'rats'), ('UBERON_0000104', 'life cycle', 83, 'life'), ('CHEBI_33290', 'food', 103, 'food'), ('GO_0007631', 'feeding behavior', 103, 'food intake'), ('UBERON_0000104', 'life cycle', 174, 'life'), ('PR_000012059', 'oncostatin-M', 211, 'ObRb'), ('PR_000009693', 'transcription factor LBX1', 219, 'leptin receptor b isoform'), ('SO_0001060', 'sequence_variant', 237, 'isoform'), ('GO_0010467', 'gene expression', 246, 'expression'), ('UBERON_0001898', 'hypothalamus', 264, 'hypothalamus')]
PMC4663588	11/2015	S383-PMC4663588	['in the Rat, at 14.5 days Gestation, Neuropeptide Y (Npy) Neurons appear in the Arcuate and dorsolateral Hypothalamus first [175,178,179] following by a rapidly increased Npy mrna Expression between 2 and 15–16 days after Birth.']	N/A	N/A	[('NCBITaxon_9986', 'Oryctolagus cuniculus', 7, 'rat'), ('GO_0007565', 'female pregnancy', 25, 'gestation'), ('PR_000011469', 'high affinity nerve growth factor receptor', 36, 'neuropeptide Y'), ('PR_000011368', 'N-acetylneuraminate lyase', 52, 'NPY'), ('CL_0000540', 'neuron', 57, 'neurons'), ('UBERON_0001876', 'amygdala', 79, 'arcuate'), ('UBERON_0001898', 'hypothalamus', 104, 'hypothalamus'), ('PR_000011368', 'N-acetylneuraminate lyase', 170, 'NPY'), ('GO_0010467', 'gene expression', 179, 'expression'), ('GO_0007567', 'parturition', 221, 'birth')]
PMC4663588	11/2015	S392-PMC4663588	['pro-opiomelanocortin (Pomc), Agrp, and Mc4R mrna are also all present in the Hypothalamus in early Postnatal period.']	N/A	N/A	[('PR_000013030', 'NADPH--cytochrome P450 reductase', 22, 'POMC'), ('PR_000003580', 'ABI gene family member 3', 29, 'AgRP'), ('PR_000001244', 'long-wave-sensitive opsin 1', 39, 'MC4R'), ('UBERON_0001898', 'hypothalamus', 77, 'hypothalamus'), ('GO_0007567', 'parturition', 99, 'postnatal')]
PMC4663588	11/2015	S397-PMC4663588	['moreover, it resulted in morphological alterations in Hypothalamus that persist in Adult Life [187,188,189].']	N/A	N/A	[('UBERON_0001898', 'hypothalamus', 54, 'hypothalamus'), ('UBERON_0000113', 'post-juvenile adult stage', 83, 'adult life')]
PMC4663588	11/2015	S404-PMC4663588	['mtor is one of the regulators of Feeding behavior and integrates neuro-endocrine signals with Nutrient signals from Gastro-Intestinal Tract in the Hypothalamus.']	N/A	N/A	[('GO_0007631', 'feeding behavior', 33, 'feeding'), ('CHEBI_33284', 'nutrient', 94, 'nutrient'), ('UBERON_0001555', 'digestive tract', 116, 'gastro-intestinal tract'), ('UBERON_0001898', 'hypothalamus', 147, 'hypothalamus')]
PMC4701936	1/2016	S4-PMC4701936	['exposure to a palatable diet resulted in low weight offspring who exhibited low Hypothalamic contents of arachidonic acid and the two major Endocannabinoids (Anandamide and 2-Arachidonoylglycerol) at Birth.']	N/A	N/A	[('UBERON_0001898', 'hypothalamus', 80, 'hypothalamic'), ('CHEBI_50904', 'allergen', 140, 'endocannabinoids'), ('CHEBI_2700', 'anandamide', 158, 'anandamide'), ('CHEBI_52392', '2-arachidonoylglycerol', 173, '2-arachidonoylglycerol'), ('GO_0007567', 'parturition', 200, 'birth')]
PMC4701936	1/2016	S78-PMC4701936	['at pn day 0, Endocannabinoid (ecb) levels extracted from the Hypothalamus and hippocampus of male offspring were measured.']	N/A	N/A	[('CHEBI_67198', 'retinoic acid receptor agonist', 13, 'endocannabinoid'), ('UBERON_0001898', 'hypothalamus', 61, 'hypothalamus')]
PMC4701936	1/2016	S96-PMC4701936	['for the isolation of the Brain Regions selected, Brains were thawed in cold Tris-Hcl buffer (50 mm, ph = 7.40) and the entire Hypothalamus and right hippocampus were immediately isolated and frozen at −80°c until Lipid extraction.']	N/A	N/A	[('UBERON_0002616', 'regional part of brain', 25, 'brain regions'), ('UBERON_0000955', 'brain', 49, 'brains'), ('CHEBI_9754', 'tris', 76, 'Tris'), ('CHEBI_17883', 'hydrogen chloride', 81, 'HCl'), ('UBERON_0001898', 'hypothalamus', 126, 'hypothalamus'), ('CHEBI_18059', 'lipid', 213, 'lipid')]
PMC4701936	1/2016	S105-PMC4701936	['the concentrations of internal standards, as well as the calibration curves, were set and tailored using test Hypothalamus and Hippocampal Tissues.']	N/A	N/A	[('UBERON_0001898', 'hypothalamus', 110, 'hypothalamus'), ('UBERON_0001954', "Ammon's horn", 127, 'hippocampal'), ('UBERON_0000479', 'tissue', 139, 'tissues')]
PMC4701936	1/2016	S172-PMC4701936	['these results demonstrate that male offspring from free-choice diet dams had lower levels of the main Endocannabinoids, their direct Metabolite, aa, as well as pea in the Hypothalamus as compared to controls at Birth.']	N/A	N/A	[('CHEBI_50904', 'allergen', 102, 'endocannabinoids'), ('CHEBI_39382', 'flufenoxuron', 133, 'metabolite'), ('UBERON_0001898', 'hypothalamus', 171, 'hypothalamus'), ('GO_0007567', 'parturition', 211, 'birth')]
PMC4701936	1/2016	S173-PMC4701936	['caption (fig): figure 4\n\nlevels of Endocannabinoids and N-Acylethanolamides in the Hypothalamus and hippocampus of male offspring .']	N/A	N/A	[('CHEBI_50904', 'allergen', 35, 'endocannabinoids'), ('CHEBI_21763', 'N-methylethanolamine', 56, 'N-acylethanolamides'), ('UBERON_0001898', 'hypothalamus', 83, 'hypothalamus')]
PMC4701936	1/2016	S174-PMC4701936	['Tissular contents (ng/g or mg/g of protein) of aea (a,f) , 2-Ag (b,g) , aa (c,h) , oea (d,i) , and pea (e,j) in the Hypothalamus and hippocampus respectively of male pups Born from mothers Fed with control diet (open bars) or free-choice diet (solid bars).']	N/A	N/A	[('UBERON_0000479', 'tissue', 0, 'Tissular'), ('CHEBI_51383', 'hydridocarbon(3.)', 59, '2-AG'), ('UBERON_0001898', 'hypothalamus', 116, 'hypothalamus'), ('GO_0007567', 'parturition', 171, 'born'), ('GO_0007631', 'feeding behavior', 189, 'fed')]
PMC4721332	11/2014	S7-PMC4721332	['introduction\nthe Acute Stress Response, characterized by activation of the Sympathetic Nervous System, the Hypothalamus-Pituitary-Adrenal axis and the Immune System, is a physiologically Adaptive Response that enables the Organism to deal with environmental threats.']	N/A	N/A	[('GO_0006953', 'acute-phase response', 17, 'acute stress response'), ('UBERON_0000013', 'sympathetic nervous system', 75, 'sympathetic nervous system'), ('UBERON_0001898', 'hypothalamus', 107, 'hypothalamus'), ('UBERON_0002109', 'pair of nares', 120, 'pituitary'), ('UBERON_0002369', 'adrenal gland', 130, 'adrenal'), ('UBERON_0002405', 'immune system', 151, 'immune system'), ('GO_0006953', 'acute-phase response', 187, 'adaptive response'), ('NCBITaxon_1', 'root', 222, 'organism')]
PMC4721332	11/2014	S185-PMC4721332	['Mice exposed to pns (via variable stress) during the first week of Gestation were shown to have increased Dna Methylation of the gr Promoter region in the Hypothalamus (mueller and bale, 2008).']	N/A	N/A	[('NCBITaxon_10088', 'Mus <genus>', 0, 'Mice'), ('GO_0007565', 'female pregnancy', 67, 'gestation'), ('GO_0006306', 'DNA methylation', 106, 'DNA methylation'), ('SO_0000167', 'promoter', 132, 'promoter'), ('UBERON_0001898', 'hypothalamus', 155, 'hypothalamus')]
PMC4789467	3/2016	S190-PMC4789467	['Calorie restriction (50% of ad libitum ) from day 14 through to weaning alters the structural development of the Hypothalamus and hippocampus, by changing the production of Brain-Derived Neurotrophic Factor (Bdnf) and Cell Proliferation during development (coupe et al.,2009).']	N/A	N/A	[('CHEBI_17245', 'carbon monoxide', 0, 'Calorie'), ('UBERON_0001898', 'hypothalamus', 113, 'hypothalamus'), ('PR_000004732', 'bifunctional apoptosis regulator', 173, 'brain-derived neurotrophic factor'), ('UBERON_0000955', 'brain', 173, 'brain'), ('PR_000004716', 'brain-derived neurotrophic factor', 208, 'BDNF'), ('GO_0008283', 'cell proliferation', 218, 'cell proliferation')]
PMC4843009	4/2016	S28-PMC4843009	['the Vitamin D receptor (vdr) and Vitamin D Metabolizing enzymes are Expressed widely in Cerebral structures including Prefrontal Cortex, hippocampus, Cingulate Gyrus, Thalamus, Hypothalamus, and Substantia Nigra46.']	N/A	N/A	[('CHEBI_27300', 'vitamin D', 4, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 33, 'vitamin D'), ('GO_0043181', 'vacuolar sequestering', 33, 'vitamin D metabolizing'), ('GO_0010467', 'gene expression', 68, 'expressed'), ('UBERON_0001893', 'telencephalon', 88, 'cerebral'), ('UBERON_0000451', 'prefrontal cortex', 118, 'prefrontal cortex'), ('UBERON_0002967', 'cingulate gyrus', 150, 'cingulate gyrus'), ('UBERON_0001897', 'dorsal plus ventral thalamus', 167, 'thalamus'), ('UBERON_0001898', 'hypothalamus', 177, 'hypothalamus'), ('UBERON_0006114', 'lateral occipital cortex', 195, 'substantia nigra46')]
PMC4846845	4/2016	S212-PMC4846845	['the Placenta is also capable of synthesizing crh to supplement crh synthesized by the Hypothalamus [168].']	N/A	N/A	[('UBERON_0001987', 'placenta', 4, 'placenta'), ('UBERON_0001898', 'hypothalamus', 86, 'hypothalamus')]
PMC4892656	6/2016	S20-PMC4892656	['in sprague dawley Rats, a high-fat cafeteria diet for 5-week before Mating and throughout Gestation and Lactation led to adiposity, Glucose intolerance, hyperlipidaemia and reduced Hypothalamic Neuropeptide Y and increased proopiomelanocortin mrna Expression in offspring, and this was amplified by Postnatal Overnutrition [9].']	N/A	N/A	[('NCBITaxon_9986', 'Oryctolagus cuniculus', 18, 'rats'), ('GO_0007618', 'mating', 68, 'mating'), ('GO_0007565', 'female pregnancy', 90, 'gestation'), ('GO_0007595', 'lactation', 104, 'lactation'), ('CHEBI_17234', 'glucose', 132, 'glucose'), ('UBERON_0001898', 'hypothalamus', 181, 'hypothalamic'), ('PR_000011469', 'high affinity nerve growth factor receptor', 194, 'neuropeptide Y'), ('GO_0010467', 'gene expression', 248, 'expression'), ('GO_0007567', 'parturition', 299, 'postnatal'), ('GO_0006704', 'glucocorticoid biosynthetic process', 309, 'overnutrition')]
PMC4905827	1/2016	S86-PMC4905827	['[37] reported that the occurrence of follicular cysts is due to the suppression of the surge in the Luteinizing hormone (lh) concentrations produced in the Hypothalamus when the Progesterone concentration is between 0.1 and 1.0 n g/m l .']	N/A	N/A	[('GO_0001905', 'activation of membrane attack complex', 100, 'luteinizing'), ('UBERON_0001898', 'hypothalamus', 156, 'hypothalamus'), ('CHEBI_17026', 'progesterone', 178, 'progesterone')]
PMC4908484	6/2016	S12-PMC4908484	['vdr is Expressed in several regions (tetich et\xa0al.2004) of Animal (garcion et\xa0al.2002) and Human (kalueff et\xa0al.2006) Brains, particularly in the pontine‐Midbrain area, Cerebellum, Thalamus, Hypothalamus, Basal Ganglia, hippocampus, Olfactory System and Temporal, Orbital and Cingulate areas of the Cortex (eyles et\xa0al.2003).']	N/A	N/A	[('GO_0010467', 'gene expression', 7, 'expressed'), ('NCBITaxon_33208', 'Metazoa', 59, 'animal'), ('NCBITaxon_9606', 'Homo sapiens', 91, 'human'), ('UBERON_0000955', 'brain', 118, 'brains'), ('UBERON_0001891', 'midbrain', 154, 'midbrain'), ('UBERON_0002037', 'cerebellum', 169, 'cerebellum'), ('UBERON_0001897', 'dorsal plus ventral thalamus', 181, 'thalamus'), ('UBERON_0001898', 'hypothalamus', 191, 'hypothalamus'), ('UBERON_0002420', 'basal ganglion', 205, 'basal ganglia'), ('GO_0007608', 'sensory perception of smell', 233, 'olfactory'), ('UBERON_0005725', 'olfactory system', 233, 'olfactory system'), ('UBERON_0011305', 'superficial part of temporalis', 254, 'temporal ...'), ('UBERON_0001697', 'orbit of skull', 264, 'orbital'), ('UBERON_0007841', 'furcula', 276, 'cingulate'), ('UBERON_0001851', 'cortex', 299, 'cortex')]
PMC4933715	7/2016	S132-PMC4933715	['additionally, Oxytocin Neurons directly project from the Hypothalamus to the Forebrain, the Amygdala, the hippocampus, and the Nucleus Accumbens.']	N/A	N/A	[('CHEBI_7872', 'oxytocin', 14, 'oxytocin'), ('CL_0000527', 'efferent neuron', 14, 'oxytocin neurons'), ('UBERON_0001898', 'hypothalamus', 57, 'hypothalamus'), ('UBERON_0001890', 'forebrain', 77, 'forebrain'), ('UBERON_0001876', 'amygdala', 92, 'amygdala'), ('UBERON_0001882', 'nucleus accumbens', 127, 'nucleus accumbens')]
PMC4954778	7/2016	S5-PMC4954778	['Hypothalamic Gene Expression of Feeding-related neuropeptides including Neuropeptide Y, pro-opiomelanocortin (Pomc), Insulin receptor, leptin receptor, Brain-Derived Neurotrophic Factor (Bdnf), receptors for Dopamine (Dopar1/2/5) and Serotonin (Seror1A/2a/2c), as well as global Dna Methylation and Brain and Plasma Folate concentrations were measured at 29 weeks post-weaning.']	N/A	N/A	[('UBERON_0001898', 'hypothalamus', 0, 'Hypothalamic'), ('GO_0010467', 'gene expression', 13, 'gene expression'), ('SO_0000704', 'gene', 13, 'gene'), ('GO_0007631', 'feeding behavior', 32, 'feeding'), ('PR_000011469', 'high affinity nerve growth factor receptor', 72, 'neuropeptide Y'), ('PR_000013030', 'NADPH--cytochrome P450 reductase', 110, 'POMC'), ('PR_000045358', 'insulin family protein', 117, 'insulin'), ('PR_000004732', 'bifunctional apoptosis regulator', 152, 'brain-derived neurotrophic factor'), ('UBERON_0000955', 'brain', 152, 'brain'), ('PR_000004716', 'brain-derived neurotrophic factor', 187, 'BDNF'), ('CHEBI_18243', 'dopamine', 208, 'dopamine'), ('CHEBI_52091', '3-chloroperbenzoic acid', 218, 'DopaR1'), ('PR_000002325', 'dynein light chain 1, cytoplasmic', 218, 'DopaR1'), ('CHEBI_28790', 'serotonin', 234, 'serotonin'), ('PR_000014662', 'selenoprotein W', 245, 'SeroR1A'), ('GO_0006306', 'DNA methylation', 279, 'DNA methylation'), ('UBERON_0000955', 'brain', 299, 'brain'), ('UBERON_0001969', 'blood plasma', 309, 'plasma'), ('CHEBI_30863', '5-azaorotic acid', 316, 'folate')]
PMC4954778	7/2016	S45-PMC4954778	['the Brains were thawed on ice and the right and left sides of the Hypothalamus were dissected separately using the method described previously.14the Optic Chiasma was used as demarcation for the anterior part of the Hypothalamus.']	N/A	N/A	[('UBERON_0000955', 'brain', 4, 'brains'), ('UBERON_0001898', 'hypothalamus', 66, 'hypothalamus'), ('UBERON_0000959', 'optic chiasma', 149, 'optic chiasma'), ('UBERON_0001898', 'hypothalamus', 216, 'hypothalamus')]
PMC4954778	7/2016	S47-PMC4954778	['the line between the posterior Hypothalamus and the Mammillary Bodies was considered a caudal section.']	N/A	N/A	[('UBERON_0001898', 'hypothalamus', 31, 'hypothalamus'), ('UBERON_0002487', 'tooth cavity', 52, 'mammillary bodies')]
PMC4954778	7/2016	S48-PMC4954778	['the dissected Hypothalamic blocks contained preoptic, Supraoptic, Paraventricular, anterior, Suprachiasmatic, dorsomedial, ventromedial, arcuate, Mammillary, posterior and lateral complex Nuclei.']	N/A	N/A	[('UBERON_0001898', 'hypothalamus', 14, 'hypothalamic'), ('UBERON_0001450', 'calcaneus', 54, 'supraoptic'), ('UBERON_0004683', 'parasubiculum', 66, 'paraventricular'), ('UBERON_0002010', 'celiac nerve plexus', 93, 'suprachiasmatic'), ('UBERON_0002397', 'maxilla', 146, 'mammillary'), ('UBERON_0000390', 'lens nucleus', 188, 'nuclei')]
PMC4954778	7/2016	S49-PMC4954778	['the right side of the Hypothalamus was used for relative Gene Expression and the left side for Dna Methylation status.']	N/A	N/A	[('UBERON_0001898', 'hypothalamus', 22, 'hypothalamus'), ('GO_0010467', 'gene expression', 57, 'gene expression'), ('SO_0000704', 'gene', 57, 'gene'), ('GO_0006306', 'DNA methylation', 95, 'DNA methylation')]
PMC4954778	7/2016	S52-PMC4954778	['Hypothalamic Gene Expression\neach dissected Hypothalamus was homogenized using a Tissue ruptor homogenizer (qiagen tech., mississauga, on, canada).']	N/A	N/A	[('UBERON_0001898', 'hypothalamus', 0, 'Hypothalamic'), ('GO_0010467', 'gene expression', 13, 'Gene Expression'), ('SO_0000704', 'gene', 13, 'Gene'), ('UBERON_0001898', 'hypothalamus', 44, 'hypothalamus'), ('UBERON_0000479', 'tissue', 81, 'tissue')]
PMC4954778	7/2016	S59-PMC4954778	['Folate concentration analysis\nPlasma and Brain Folate concentrations were determined by the microbiological microtiter plate assay using lactobacillus casei .16,17\n\nHypothalamic global Dna Methylation analysis\ndna was isolated using the protocol outlined by the dneasy Blood and Tissue kit (qiagen tech., mississauga, on, canada).']	N/A	N/A	[('CHEBI_81245', 'Vulpecholate', 0, 'Folate'), ('UBERON_0001969', 'blood plasma', 30, 'Plasma'), ('UBERON_0000955', 'brain', 41, 'brain'), ('CHEBI_30863', '5-azaorotic acid', 47, 'folate'), ('UBERON_0001898', 'hypothalamus', 165, 'Hypothalamic'), ('GO_0006306', 'DNA methylation', 185, 'DNA Methylation'), ('UBERON_0000178', 'blood', 269, 'Blood'), ('UBERON_0000479', 'tissue', 279, 'Tissue')]
PMC4954778	7/2016	S61-PMC4954778	['global methylation status of Hypothalamic Genomic dna was determined by the in vitro methyl acceptance assay method as described previously.18,19this assay involves3h-methyl-s-Adenosylmethionine (new england Nuclear, boston, ma, usa) as a Methyl donor mediated by Sss1 dna methyltransferase (new england biolabs, pickering, on, canada).']	N/A	N/A	[('UBERON_0001898', 'hypothalamus', 29, 'hypothalamic'), ('SO_0001026', 'genome', 42, 'genomic'), ('CHEBI_22205', 'acetylspermine', 176, 'adenosylmethionine'), ('GO_0005634', 'nucleus', 208, 'Nuclear'), ('CHEBI_32875', 'methyl group', 239, 'methyl'), ('PR_000014775', 'pulmonary surfactant-associated protein D', 264, 'Sss1')]
PMC4954778	7/2016	S66-PMC4954778	['the means at each time point and for Hypothalamic Gene Expression, Folate status and Glucose response were compared by one-way analysis of variance using the proc glm followed by a tukey’s post-hoc test.']	N/A	N/A	[('UBERON_0001898', 'hypothalamus', 37, 'hypothalamic'), ('GO_0010467', 'gene expression', 50, 'gene expression'), ('SO_0000704', 'gene', 50, 'gene'), ('CHEBI_30863', '5-azaorotic acid', 67, 'folate'), ('CHEBI_17234', 'glucose', 85, 'glucose')]
PMC4954778	7/2016	S76-PMC4954778	['there was no effect of the Gestational or pup diets on Hypothalamic Expression of other Genes.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 27, 'gestational'), ('UBERON_0001898', 'hypothalamus', 55, 'hypothalamic'), ('GO_0010467', 'gene expression', 68, 'expression'), ('SO_0000704', 'gene', 88, 'genes')]
PMC5019390	9/2016	S13-PMC5019390	['maternal high fat Feeding also significantly altered the Hypothalamic Expression of key Genes encoding for proteins involved in the Regulation Of Food Intake and Energy Homeostasis, such as the Neuropeptide Y (Npy) [7], and in many case, the proopiomelanocortin (Pomc) system [8,9].']	N/A	N/A	[('GO_0007631', 'feeding behavior', 18, 'feeding'), ('UBERON_0001898', 'hypothalamus', 57, 'hypothalamic'), ('GO_0010467', 'gene expression', 70, 'expression'), ('SO_0000704', 'gene', 88, 'genes'), ('GO_0051621', 'regulation of norepinephrine uptake', 132, 'regulation of food intake'), ('CHEBI_33290', 'food', 146, 'food'), ('GO_0097009', 'energy homeostasis', 162, 'energy homeostasis'), ('PR_000011469', 'high affinity nerve growth factor receptor', 194, 'neuropeptide Y'), ('PR_000011368', 'N-acetylneuraminate lyase', 210, 'NPY'), ('PR_000013030', 'NADPH--cytochrome P450 reductase', 263, 'POMC')]
PMC5019390	9/2016	S37-PMC5019390	['for Hypothalamic Gene Expression and Blood parameters, a second cohort (cohort 2) was euthanized at pnd0, pnd7, pnd10, pnd14, pnd17, pnd21, and pnd28 (fig 1a).']	N/A	N/A	[('UBERON_0001898', 'hypothalamus', 4, 'hypothalamic'), ('GO_0010467', 'gene expression', 17, 'gene expression'), ('SO_0000704', 'gene', 17, 'gene'), ('UBERON_0000178', 'blood', 37, 'blood')]
PMC5019390	9/2016	S65-PMC5019390	['Tissue processing and analyses of Gene Expression\ntotal rnas from Hypothalami were extracted using a single-step extraction with trizol Reagent (sigma-aldrich, buchs, switzerland).']	N/A	N/A	[('UBERON_0000479', 'tissue', 0, 'Tissue'), ('GO_0010467', 'gene expression', 34, 'gene expression'), ('SO_0000704', 'gene', 34, 'gene'), ('UBERON_0001898', 'hypothalamus', 66, 'hypothalami'), ('CHEBI_33893', 'reagent', 136, 'reagent')]
PMC5019390	9/2016	S103-PMC5019390	['the Expression of the leptin receptor ( Obrb ) was also examined.10.1371/journal.pone.0162517.g003\n\ncaption (fig): fig 3\neffect of a Perinatal hf diet on Hypothalamic neuropeptide mrna Expression in wistar and lou/c male Rats.']	N/A	N/A	[('GO_0010467', 'gene expression', 4, 'expression'), ('PR_000011593', 'ovarian cancer-related protein 1', 40, 'Obrb'), ('GO_0036268', 'swimming', 133, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 133, 'perinatal'), ('UBERON_0001898', 'hypothalamus', 154, 'hypothalamic'), ('GO_0010467', 'gene expression', 185, 'expression'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 221, 'rats')]
PMC5019390	9/2016	S106-PMC5019390	['Hypothalamic mrna Expression of Pomc (b), Bdnf (c) and agrp (d) in psd (n = 3) and phf wistar (n = 3–4) and psd (n = 3) and phf lou/c Rats (n = 3–6).']	N/A	N/A	[('UBERON_0001898', 'hypothalamus', 0, 'Hypothalamic'), ('GO_0010467', 'gene expression', 18, 'expression'), ('PR_000013508', 'PX domain-containing protein kinase-like protein', 32, 'Pomc'), ('PR_000004712', 'breakpoint cluster region protein', 42, 'Bdnf'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 134, 'rats')]
PMC5019390	9/2016	S108-PMC5019390	['e) Hypothalamic mrna Expression of Obrb .']	N/A	N/A	[('UBERON_0001898', 'hypothalamus', 3, 'Hypothalamic'), ('GO_0010467', 'gene expression', 21, 'expression'), ('PR_000011593', 'ovarian cancer-related protein 1', 35, 'Obrb')]
PMC5019390	9/2016	S126-PMC5019390	['b) Hypothalamic mrna Expression of Pomc , agrp , mc4r , Obrb and Bdnf in wistar and lou/c Rats.']	N/A	N/A	[('UBERON_0001898', 'hypothalamus', 3, 'Hypothalamic'), ('GO_0010467', 'gene expression', 21, 'expression'), ('PR_000013508', 'PX domain-containing protein kinase-like protein', 35, 'Pomc'), ('PR_000011593', 'ovarian cancer-related protein 1', 56, 'Obrb'), ('PR_000004712', 'breakpoint cluster region protein', 65, 'Bdnf'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 90, 'rats')]
PMC5019390	9/2016	S132-PMC5019390	['regarding Hypothalamic Gene Expression, significant modifications of the Melanocortin system were observed in wistar male Rats (fig 4b).']	N/A	N/A	[('UBERON_0001898', 'hypothalamus', 10, 'hypothalamic'), ('GO_0010467', 'gene expression', 23, 'gene expression'), ('SO_0000704', 'gene', 23, 'gene'), ('PR_000010435', 'homeobox protein Mohawk', 73, 'melanocortin'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 122, 'rats')]
PMC5019390	9/2016	S168-PMC5019390	['e) Hypothalamic mrna Expression of Pomc , agrp , mc4r , Obrb and Bdnf .']	N/A	N/A	[('UBERON_0001898', 'hypothalamus', 3, 'Hypothalamic'), ('GO_0010467', 'gene expression', 21, 'expression'), ('PR_000013508', 'PX domain-containing protein kinase-like protein', 35, 'Pomc'), ('PR_000011593', 'ovarian cancer-related protein 1', 56, 'Obrb'), ('PR_000004712', 'breakpoint cluster region protein', 65, 'Bdnf')]
PMC5019390	9/2016	S171-PMC5019390	['Hypothalamic mrna Expression of Socs3 .']	N/A	N/A	[('UBERON_0001898', 'hypothalamus', 0, 'Hypothalamic'), ('GO_0010467', 'gene expression', 18, 'expression'), ('PR_000015393', 'suppressor of cytokine signaling 2', 32, 'Socs3')]
PMC5025983	8/2015	S25-PMC5025983	['the Hypothalamus begins developing in an early stage of Pregnancy, and it continues to develop in Postnatal Life.']	N/A	N/A	[('UBERON_0001898', 'hypothalamus', 4, 'hypothalamus'), ('GO_0007565', 'female pregnancy', 56, 'pregnancy'), ('GO_0007567', 'parturition', 98, 'postnatal'), ('UBERON_0000104', 'life cycle', 108, 'life')]
PMC5025983	8/2015	S29-PMC5025983	['methods\n\nsearch strategy and selection of studies\nto identify eligible studies for this rewiev, a computerized search was performed for all publications available up to march 2013 through pubmed, web of science, and embase databases using the following key words: ‘dietary Fatty Acids’, ‘dietary Lipids’, ‘Omega-3 Fatty Acids’, ‘maternal high fat diet’, ‘maternal fat intake’, ‘maternal obesity’, ‘fetal programming’, Metabolic Programming’, ‘fetal origins of obesity’, ‘early Life nutrition’, ‘Maternal nutrition’, ‘Hypothalamic Programming’, ‘developmental programming’, ‘Placental Lipid Transfer’, ‘Maternal Fatty Acid transfer’ and ‘Prenatal Fatty Acid status.’ reference lists from identified articles and relevant reviews were examined for studies not indexed in the mentioned electronic databases.']	N/A	N/A	[('CHEBI_35366', 'fatty acid', 273, 'fatty acids'), ('CHEBI_18059', 'lipid', 296, 'lipids'), ('CHEBI_75862', 'alpha-D-rhamnofuranose', 306, 'omega-3 fatty acids'), ('GO_0006402', 'mRNA catabolic process', 418, 'metabolic programming'), ('UBERON_0000104', 'life cycle', 477, 'life'), ('GO_0007618', 'mating', 495, 'maternal'), ('GO_0021588', 'cerebellum formation', 517, 'hypothalamic programming'), ('UBERON_0001898', 'hypothalamus', 517, 'hypothalamic'), ('GO_0009344', 'nitrite reductase complex [NAD(P)H]', 574, 'placental lipid transfer'), ('UBERON_0001987', 'placenta', 574, 'placental'), ('CHEBI_18059', 'lipid', 584, 'lipid'), ('GO_0007618', 'mating', 602, 'maternal'), ('CHEBI_35366', 'fatty acid', 611, 'fatty acid'), ('GO_0007565', 'female pregnancy', 637, 'prenatal'), ('CHEBI_33250', 'atom', 646, 'fatty'), ('CHEBI_37527', 'acid', 652, 'acid')]
PMC5025983	8/2015	S164-PMC5025983	['high fat nutrition during Pregnancy and Lactation causes hyperphagia and obesity in the offspring, and it disrupts Hypothalamic Gene Expression [18,68].']	N/A	N/A	[('GO_0007565', 'female pregnancy', 26, 'pregnancy'), ('GO_0007595', 'lactation', 40, 'lactation'), ('UBERON_0001898', 'hypothalamus', 115, 'hypothalamic'), ('GO_0010467', 'gene expression', 128, 'gene expression'), ('SO_0000704', 'gene', 128, 'gene')]
PMC5025983	8/2015	S170-PMC5025983	['when these hormones penetrate the Blood–Brain barrier, neural signals in the acute nucleus part of the Hypothalamus also take part in Regulating energy balance.']	N/A	N/A	[('UBERON_0000178', 'blood', 34, 'blood'), ('UBERON_0000955', 'brain', 40, 'brain'), ('UBERON_0001898', 'hypothalamus', 103, 'hypothalamus'), ('GO_0065007', 'biological regulation', 134, 'regulating')]
PMC5025983	8/2015	S187-PMC5025983	['the Hypothalamic melanocortin system, which Controls Appetite and energy consumption, develops during the last trimester.']	N/A	N/A	[('UBERON_0001898', 'hypothalamus', 4, 'hypothalamic'), ('GO_0065007', 'biological regulation', 44, 'controls'), ('GO_0000239', 'pachytene', 53, 'appetite')]
PMC5045149	9/2016	S82-PMC5045149	['anxiety behaviors and symptoms are predominantly activated through the Ans and the Hypothalamus-Pituitary-Adrenal axis (hpa).']	N/A	N/A	[('UBERON_0001363', 'great saphenous vein', 71, 'ANS'), ('UBERON_0001898', 'hypothalamus', 83, 'hypothalamus'), ('UBERON_0002109', 'pair of nares', 96, 'pituitary'), ('UBERON_0002369', 'adrenal gland', 106, 'adrenal')]
PMC5045149	9/2016	S96-PMC5045149	['the Amygdala, and its extension via the Bnst, go on to Innervate the Lc and Hypothalamus through Corticotropin-Releasing Factor (Crf), and thus the cascade of stress induced response propagates throughout the Ans (via na) and systemic adrenergic receptors.']	N/A	N/A	[('UBERON_0001876', 'amygdala', 4, 'amygdala'), ('UBERON_0001348', 'brown adipose tissue', 40, 'BNST'), ('GO_0060384', 'innervation', 55, 'innervate'), ('UBERON_2000120', 'lateral line ganglion', 69, 'LC'), ('UBERON_0001898', 'hypothalamus', 76, 'hypothalamus'), ('PR_000005890', 'crooked neck-like protein 1', 97, 'corticotropin-releasing factor'), ('PR_000005890', 'crooked neck-like protein 1', 129, 'CRF'), ('UBERON_0001363', 'great saphenous vein', 209, 'ANS')]
PMC5088205	11/2016	S4-PMC5088205	['pups from calorie-restricted dams also exhibited a strong decrease in the levels of Anandamide (Aea), 2-Arachidonoylglycerol (2-Ag), arachidonic acid (aa) and Palmitoylethanolamide (Pea) in the Hypothalamus at Birth.']	N/A	N/A	[('CHEBI_2700', 'anandamide', 84, 'anandamide'), ('CHEBI_39048', 'ADA', 96, 'AEA'), ('CHEBI_52392', '2-arachidonoylglycerol', 102, '2-arachidonoylglycerol'), ('CHEBI_51383', 'hydridocarbon(3.)', 126, '2-AG'), ('CHEBI_71464', 'palmitoyl ethanolamide', 159, 'palmitoylethanolamide'), ('CHEBI_39015', 'apolipoprotein', 182, 'PEA'), ('UBERON_0001898', 'hypothalamus', 194, 'hypothalamus'), ('GO_0007567', 'parturition', 210, 'birth')]
PMC5088205	11/2016	S69-PMC5088205	['at Birth Postnatal day 0 (pn0), Endocannabinoid and n-acylethanolamide (Nae) levels of male offspring were measured in Hypothalamus, hippocampus and Olfactory Bulb.']	N/A	N/A	[('GO_0007567', 'parturition', 3, 'birth'), ('GO_0007567', 'parturition', 9, 'postnatal'), ('CHEBI_67198', 'retinoic acid receptor agonist', 32, 'endocannabinoid'), ('CHEBI_23995', 'N-ethyl-N-nitrosourea', 72, 'NAE'), ('UBERON_0001898', 'hypothalamus', 119, 'hypothalamus'), ('GO_0007608', 'sensory perception of smell', 149, 'olfactory'), ('UBERON_0002264', 'olfactory bulb', 149, 'olfactory bulb')]
PMC5088205	11/2016	S102-PMC5088205	['for the isolation of the Brain Regions selected, Brains were thawed in cold Tris-Hcl buffer (50 mm, ph = 7.40) and the entire Hypothalamus, right hippocampus and right Olfactory Bulb were quickly isolated and immediately frozen at −80°c until Lipid extraction.']	N/A	N/A	[('UBERON_0002616', 'regional part of brain', 25, 'brain regions'), ('UBERON_0000955', 'brain', 49, 'brains'), ('CHEBI_9754', 'tris', 76, 'Tris'), ('CHEBI_17883', 'hydrogen chloride', 81, 'HCl'), ('UBERON_0001898', 'hypothalamus', 126, 'hypothalamus'), ('GO_0007608', 'sensory perception of smell', 168, 'olfactory'), ('UBERON_0002264', 'olfactory bulb', 168, 'olfactory bulb'), ('CHEBI_18059', 'lipid', 243, 'lipid')]
PMC5088205	11/2016	S187-PMC5088205	['caption (fig): figure 4\n\nHypothalamic Endocannabinoid and nae levels in male offspring at Birth.']	N/A	N/A	[('UBERON_0001898', 'hypothalamus', 25, 'Hypothalamic'), ('CHEBI_67198', 'retinoic acid receptor agonist', 38, 'endocannabinoid'), ('GO_0007567', 'parturition', 90, 'birth')]
PMC5088205	11/2016	S188-PMC5088205	['(a) Anandamide (Aea), (b) Arachidonoylglycerol (2-Ag), (c) Arachidonic Acid (aa), (d) Oleoylethanolamide (oea), and (e) Palmitoylethanolamide (Pea) in the Hypothalamus of male offspring from control dams (open bars) and calorie-restricted dams (solid bars) at Birth.']	N/A	N/A	[('CHEBI_2704', 'anastrozole', 4, 'Anandamide'), ('CHEBI_39048', 'ADA', 16, 'AEA'), ('CHEBI_76580', 'Mono-(alk-1-enyl)-glycerol', 26, 'arachidonoylglycerol'), ('CHEBI_51383', 'hydridocarbon(3.)', 48, '2-AG'), ('CHEBI_15843', 'arachidonic acid', 59, 'Arachidonic acid'), ('CHEBI_71466', 'oleoyl ethanolamide', 86, 'oleoylethanolamide'), ('CHEBI_71464', 'palmitoyl ethanolamide', 120, 'palmitoylethanolamide'), ('CHEBI_39015', 'apolipoprotein', 143, 'PEA'), ('UBERON_0001898', 'hypothalamus', 155, 'hypothalamus'), ('GO_0007567', 'parturition', 260, 'birth')]
PMC5088205	11/2016	S251-PMC5088205	['a moderate maternal Caloric restriction during the Preconceptional/Pregnancy period alters Hypothalamic and hippocampal Endocannabinoid and nae levels in male offspring at Birth\nthe Endocannabinoid system is a relevant Homeostatic network of signals Controlling energy expenditure and Metabolism (matias and di marzo,2007; bermudez-silva et al.,2010).']	N/A	N/A	[('CHEBI_81905', '3A-Deolivosylpremithramycin B', 20, 'Caloric'), ('GO_0007605', 'sensory perception of sound', 51, 'Preconceptional ...'), ('GO_0007565', 'female pregnancy', 67, 'Pregnancy'), ('UBERON_0001898', 'hypothalamus', 91, 'Hypothalamic'), ('CHEBI_84903', '22-methyltricosanoic acid', 120, 'Endocannabinoid'), ('GO_0007567', 'parturition', 172, 'Birth'), ('CHEBI_67198', 'retinoic acid receptor agonist', 182, 'endocannabinoid'), ('GO_0042592', 'homeostatic process', 219, 'homeostatic'), ('GO_0065007', 'biological regulation', 250, 'controlling'), ('GO_0008152', 'metabolic process', 285, 'metabolism')]
PMC5088205	11/2016	S258-PMC5088205	['in the Hypothalamus, we detected a strong reduction in the level of the main Endocannabinoids and Aa.']	N/A	N/A	[('UBERON_0001898', 'hypothalamus', 7, 'hypothalamus'), ('CHEBI_50904', 'allergen', 77, 'endocannabinoids'), ('CHEBI_27718', "alpha-Fuc-(1->2)-[alpha-Fuc-(1->2)-beta-Gal-(1->3)-alpha-GalNAc-(1->3)]-beta-Gal-(1->4)-beta-GlcNAc-(1->3)-beta-Gal-(1->4)-beta-Glc-(1<->1')-Cer", 98, 'AA')]
PMC5091916	11/2016	S19-PMC5091916	['they include leptin dysregulation [17], epigenetic phenomenons [18], alterations in the Hypothalamic neuropeptides [19] or modifications in Opioid and Dopamine Signaling of the central reward system [16,18].']	N/A	N/A	[('UBERON_0001898', 'hypothalamus', 88, 'hypothalamic'), ('CHEBI_35701', 'ester', 140, 'opioid'), ('GO_0007608', 'sensory perception of smell', 140, 'opioid ...'), ('CHEBI_18243', 'dopamine', 151, 'dopamine'), ('GO_0007212', 'dopamine receptor signaling pathway', 151, 'dopamine signaling')]
PMC5091916	11/2016	S80-PMC5091916	['additionally, the characterization of the ecs, Lipid Metabolism and ppars Gene Expression was evaluated in Metabolically-relevant Tissues (Hypothalamus, Liver and Pat).']	N/A	N/A	[('CHEBI_18059', 'lipid', 47, 'lipid'), ('GO_0006629', 'lipid metabolic process', 47, 'lipid metabolism'), ('GO_0010467', 'gene expression', 74, 'gene expression'), ('SO_0000704', 'gene', 74, 'gene'), ('GO_0008152', 'metabolic process', 107, 'metabolically'), ('UBERON_0000479', 'tissue', 130, 'tissues'), ('UBERON_0001898', 'hypothalamus', 139, 'hypothalamus'), ('UBERON_0002107', 'liver', 153, 'liver'), ('UBERON_0004363', 'pharyngeal arch artery', 163, 'PAT')]
PMC5091916	11/2016	S117-PMC5091916	['then, the Hypothalamus was sectioned according to the Rat Brain atlas of paxinos and watson (1998) [45] by a punch done at coronal planes, and immediately processed for mrna isolation.']	N/A	N/A	[('UBERON_0001898', 'hypothalamus', 10, 'hypothalamus'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 54, 'rat'), ('UBERON_0000955', 'brain', 58, 'brain')]
PMC5091916	11/2016	S118-PMC5091916	['the Hypothalamic area analyzed was ventral to the Thalamus, caudal to Preoptic area and dorsal to the Mammillary Bodies.']	N/A	N/A	[('UBERON_0001898', 'hypothalamus', 4, 'hypothalamic'), ('UBERON_0001897', 'dorsal plus ventral thalamus', 50, 'thalamus'), ('UBERON_2000442', 'supraneural bone', 70, 'preoptic'), ('UBERON_0002487', 'tooth cavity', 102, 'mammillary bodies')]
PMC5091916	11/2016	S131-PMC5091916	['Tissue portions (100–300 mg) of the Liver, Pat and the whole Hypothalamus were homogenized.']	N/A	N/A	[('UBERON_0000479', 'tissue', 0, 'Tissue'), ('UBERON_0002107', 'liver', 36, 'liver'), ('UBERON_0004363', 'pharyngeal arch artery', 43, 'PAT'), ('UBERON_0001898', 'hypothalamus', 61, 'hypothalamus')]
PMC5091916	11/2016	S443-PMC5091916	['effect of maternal diet on Endocannabinoid Metabolism Gene Expression on the Hypothalamus, Liver and Pat of offspring at Adulthood\nGene Expression levels of several ecs components ( cnr1 , Cnr2 , Napepld , faah , Daglα , Daglβ , mgll ) were evaluated in male and female offspring from Rat dams Fed either a standard Chow (cc) or a high caloric diet (pc) in the Hypothalamus, Liver and Perirenal Adipose Tissue (Pat).']	N/A	N/A	[('CHEBI_67198', 'retinoic acid receptor agonist', 27, 'endocannabinoid'), ('GO_0046584', 'enniatin metabolic process', 27, 'endocannabinoid metabolism'), ('GO_0010467', 'gene expression', 54, 'gene expression'), ('SO_0000704', 'gene', 54, 'gene'), ('UBERON_0001898', 'hypothalamus', 77, 'hypothalamus'), ('UBERON_0002107', 'liver', 91, 'liver'), ('UBERON_0004363', 'pharyngeal arch artery', 101, 'PAT'), ('UBERON_0000113', 'post-juvenile adult stage', 121, 'adulthood'), ('GO_0010467', 'gene expression', 131, 'Gene expression'), ('SO_0000704', 'gene', 131, 'Gene'), ('PR_000004968', 'calretinin', 189, 'Cnr2'), ('PR_000011593', 'ovarian cancer-related protein 1', 196, 'Napepld'), ('PR_000006490', 'solute carrier family 49 member 4', 213, 'Daglα'), ('PR_000006447', 'diacylglycerol kinase eta', 221, 'Daglβ'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 285, 'rat'), ('GO_0007631', 'feeding behavior', 294, 'fed'), ('CHEBI_33290', 'food', 316, 'chow'), ('UBERON_0001898', 'hypothalamus', 361, 'hypothalamus'), ('UBERON_0002107', 'liver', 375, 'liver'), ('UBERON_0001745', 'secondary nodular lymphoid tissue', 385, 'perirenal adipose tissue'), ('UBERON_0004363', 'pharyngeal arch artery', 411, 'PAT')]
PMC5091916	11/2016	S453-PMC5091916	['regarding the bonferroni analysis, pc female offspring showed an increase in the Gene Expression of cnr1 in the Hypothalamus when they were compared to pc males and cc females respectively (##/$ $ $p<0 .']	N/A	N/A	[('GO_0010467', 'gene expression', 81, 'gene expression'), ('SO_0000704', 'gene', 81, 'gene'), ('UBERON_0001898', 'hypothalamus', 112, 'hypothalamus')]
PMC5091916	11/2016	S455-PMC5091916	['001) .10.1371/journal.pone.0165432.g006\n\ncaption (fig): fig 6\nlevels of Endocannabinoid Metabolism Gene Expression in the Hypothalamus.']	N/A	N/A	[('CHEBI_67198', 'retinoic acid receptor agonist', 72, 'endocannabinoid'), ('GO_0046584', 'enniatin metabolic process', 72, 'endocannabinoid metabolism'), ('GO_0010467', 'gene expression', 99, 'gene expression'), ('SO_0000704', 'gene', 99, 'gene'), ('UBERON_0001898', 'hypothalamus', 122, 'hypothalamus')]
PMC5091916	11/2016	S536-PMC5091916	['these alterations include modifications in the Hypothalamus, Liver and Pat.']	N/A	N/A	[('UBERON_0001898', 'hypothalamus', 47, 'hypothalamus'), ('UBERON_0002107', 'liver', 61, 'liver'), ('UBERON_0004363', 'pharyngeal arch artery', 71, 'PAT')]
PMC5091916	11/2016	S737-PMC5091916	['they exhibited hyperphagia during part of their Life, increased Perigonadal adiposity but not Abdominal adiposity, alterations in lipoproteins including strong reduction of hdl and higher cnr1 Expression in Hypothalamus and Pat, along with lower Expression of Endocannabinoid-Degrading enzymes in the Liver.']	N/A	N/A	[('UBERON_0000104', 'life cycle', 48, 'life'), ('UBERON_0001179', 'peritoneal cavity', 64, 'perigonadal'), ('UBERON_0000916', 'abdomen', 94, 'abdominal'), ('GO_0010467', 'gene expression', 193, 'expression'), ('UBERON_0001898', 'hypothalamus', 207, 'hypothalamus'), ('UBERON_0004363', 'pharyngeal arch artery', 224, 'PAT'), ('GO_0010467', 'gene expression', 246, 'expression'), ('CHEBI_67198', 'retinoic acid receptor agonist', 260, 'endocannabinoid'), ('GO_0048313', 'Golgi inheritance', 260, 'endocannabinoid-degrading'), ('UBERON_0002107', 'liver', 301, 'liver')]
PMC5165167	12/2016	S116-PMC5165167	['the growth hormone weakness is due to Hypothalamic Neuronal connection failure [30,31].']	N/A	N/A	[('CL_0000743', 'hypertrophic chondrocyte', 38, 'hypothalamic neuronal'), ('UBERON_0001898', 'hypothalamus', 38, 'hypothalamic')]
PMC5187359	12/2016	S4-PMC5187359	['the Gene Expression of the Cannabinoid receptors cnr1 and Cnr2 was increased in rc male Hypothalamus, but a down-Expression of most ecbs-Metabolizing enzymes ( faah, Dagl Α , Dagl Β , mgll ) and several key regulators of Fatty-Acid Β-Oxidation ( cpt1b, acox1 ), Mitochondrial Respiration ( Cox4I1 ), and Lipid flux ( ppar γ) was found in their Pat.']	N/A	N/A	[('GO_0010467', 'gene expression', 4, 'gene expression'), ('SO_0000704', 'gene', 4, 'gene'), ('CHEBI_67194', 'cannabinoid', 27, 'cannabinoid'), ('PR_000004968', 'calretinin', 58, 'Cnr2'), ('UBERON_0001898', 'hypothalamus', 88, 'hypothalamus'), ('GO_0010467', 'gene expression', 113, 'expression'), ('GO_0008152', 'metabolic process', 137, 'metabolizing'), ('PR_000006490', 'solute carrier family 49 member 4', 166, 'Dagl α'), ('PR_000006447', 'diacylglycerol kinase eta', 175, 'Dagl β'), ('CHEBI_35366', 'fatty acid', 221, 'fatty-acid'), ('GO_0006635', 'fatty acid beta-oxidation', 221, 'fatty-acid β-oxidation'), ('GO_0005739', 'mitochondrion', 262, 'mitochondrial'), ('GO_0045333', 'cellular respiration', 276, 'respiration'), ('PR_000005793', 'cytochrome c oxidase subunit 8C, mitochondrial', 290, 'Cox4i1'), ('CHEBI_18059', 'lipid', 304, 'lipid'), ('UBERON_0004363', 'pharyngeal arch artery', 344, 'PAT')]
PMC5187359	12/2016	S20-PMC5187359	['they include epigenetic Regulation (nijland et al.,2010; martinez et al.,2014), Leptin Signaling (yura et al.,2005; palou et al.,2010), Hypothalamic Development (sebert et al.,2009; garcía et al.,2010), and Dopaminergic and Serotonergic Signaling systems (manuel-apolinar et al.,2014).']	N/A	N/A	[('GO_0065007', 'biological regulation', 24, 'regulation'), ('GO_0009099', 'valine biosynthetic process', 80, 'leptin signaling'), ('GO_0021854', 'hypothalamus development', 136, 'hypothalamic development'), ('UBERON_0001898', 'hypothalamus', 136, 'hypothalamic'), ('CHEBI_18243', 'dopamine', 207, 'dopaminergic'), ('GO_0007285', 'primary spermatocyte growth', 207, 'dopaminergic ...'), ('GO_0060035', 'notochord cell development', 224, 'serotonergic signaling')]
PMC5187359	12/2016	S33-PMC5187359	['particularly, we evaluated the Gene Expression of relevant components of the Endocannabinoid system, and key enzymes and regulators of the Lipid and Cholesterol Metabolism in Metabolically relevant Tissues, such as the Hypothalamus, the Liver, and the Perirenal Adipose Tissue (Pat), of male and female Adult offspring.']	N/A	N/A	[('GO_0010467', 'gene expression', 31, 'gene expression'), ('SO_0000704', 'gene', 31, 'gene'), ('CHEBI_67198', 'retinoic acid receptor agonist', 77, 'endocannabinoid'), ('CHEBI_18059', 'lipid', 139, 'lipid'), ('GO_0006266', 'DNA ligation', 139, 'lipid ...'), ('CHEBI_16113', 'cholesterol', 149, 'cholesterol'), ('GO_0008203', 'cholesterol metabolic process', 149, 'cholesterol metabolism'), ('GO_0008152', 'metabolic process', 175, 'metabolically'), ('UBERON_0000479', 'tissue', 198, 'tissues'), ('UBERON_0001898', 'hypothalamus', 219, 'hypothalamus'), ('UBERON_0002107', 'liver', 237, 'liver'), ('UBERON_0001745', 'secondary nodular lymphoid tissue', 252, 'perirenal adipose tissue'), ('UBERON_0004363', 'pharyngeal arch artery', 278, 'PAT'), ('UBERON_0007023', 'adult organism', 303, 'adult')]
PMC5187359	12/2016	S89-PMC5187359	['then, the Hypothalamus was dissected out from the base of the Brain according the Rat Brain atlas of paxinos and watson (2007).']	N/A	N/A	[('UBERON_0001898', 'hypothalamus', 10, 'hypothalamus'), ('UBERON_0000955', 'brain', 62, 'brain'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 82, 'rat'), ('UBERON_0000955', 'brain', 86, 'brain')]
PMC5187359	12/2016	S100-PMC5187359	["portions (100–300 mg) of Liver and Pat, and the whole Hypothalamus were homogenized in ice and rna was extracted using the trizol® method according to the manufacturer's instruction (gibco brl)."]	N/A	N/A	[('UBERON_0002107', 'liver', 25, 'liver'), ('UBERON_0004363', 'pharyngeal arch artery', 35, 'PAT'), ('UBERON_0001898', 'hypothalamus', 54, 'hypothalamus')]
PMC5187359	12/2016	S189-PMC5187359	['long-term effect of Prenatal caloric restriction on the ecs Gene Expression in Hypothalamus, Liver, and Perirenal Adipose Tissue of Adult offspring\nGene Expression of relevant ecs components ( cnr1, Cnr2, Napepld, faah, Dagl Α, Dagl Β, mgll ) was evaluated in the Hypothalamus, the Liver and the Pat of male and female offspring from Rat dams which were exposed to an ad libitum access of a standard Chow (cc) or a 20%-restricted access of the same standard Chow (rc) during Pregestational (2 weeks) and Gestational periods (figure4).']	N/A	N/A	[('GO_0007565', 'female pregnancy', 20, 'prenatal'), ('GO_0010467', 'gene expression', 60, 'gene expression'), ('SO_0000704', 'gene', 60, 'gene'), ('UBERON_0001898', 'hypothalamus', 79, 'hypothalamus'), ('UBERON_0002107', 'liver', 93, 'liver'), ('UBERON_0001745', 'secondary nodular lymphoid tissue', 104, 'perirenal adipose tissue'), ('UBERON_0007023', 'adult organism', 132, 'adult'), ('GO_0010467', 'gene expression', 148, 'Gene expression'), ('SO_0000704', 'gene', 148, 'Gene'), ('PR_000004968', 'calretinin', 199, 'Cnr2'), ('PR_000011593', 'ovarian cancer-related protein 1', 205, 'Napepld'), ('PR_000006490', 'solute carrier family 49 member 4', 220, 'Dagl α'), ('PR_000006447', 'diacylglycerol kinase eta', 228, 'Dagl β'), ('UBERON_0001898', 'hypothalamus', 264, 'hypothalamus'), ('UBERON_0002107', 'liver', 282, 'liver'), ('UBERON_0004363', 'pharyngeal arch artery', 296, 'PAT'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 334, 'rat'), ('CHEBI_33290', 'food', 400, 'chow'), ('CHEBI_33290', 'food', 458, 'chow'), ('GO_0007565', 'female pregnancy', 475, 'pregestational'), ('GO_0007565', 'female pregnancy', 504, 'gestational')]
PMC5187359	12/2016	S190-PMC5187359	['caption (fig): figure 4\n\neffect of Prenatal caloric restriction on the Gene Expression of components of the Endocannabinoid system ( cnr1 , Cnr2 , Napepld , faah , Dagl Α, Dagl Β, mgll ) in the Hypothalamus (a) , Liver (b) , and Perirenal Adipose Tissue (Pat, c ) of male and female offspring at Adulthood.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 35, 'prenatal'), ('GO_0010467', 'gene expression', 71, 'gene expression'), ('SO_0000704', 'gene', 71, 'gene'), ('CHEBI_67198', 'retinoic acid receptor agonist', 108, 'endocannabinoid'), ('PR_000004968', 'calretinin', 140, 'Cnr2'), ('PR_000011593', 'ovarian cancer-related protein 1', 147, 'Napepld'), ('PR_000006490', 'solute carrier family 49 member 4', 164, 'Dagl α'), ('PR_000006447', 'diacylglycerol kinase eta', 172, 'Dagl β'), ('UBERON_0001898', 'hypothalamus', 194, 'hypothalamus'), ('UBERON_0002107', 'liver', 213, 'liver'), ('UBERON_0001745', 'secondary nodular lymphoid tissue', 229, 'perirenal adipose tissue'), ('UBERON_0004363', 'pharyngeal arch artery', 255, 'PAT'), ('UBERON_0000113', 'post-juvenile adult stage', 296, 'adulthood')]
PMC5187359	12/2016	S276-PMC5187359	['the Adult male offspring from calorie-restricted dams specifically exhibited an increased Gene Expression of the Cannabinoid receptors cnr1 and Cnr2 in the Hypothalamus, and showed a decreased Gene Expression of the ecbs-Metabolizing enzymes Napepld in Liver, and faah, Dagl Α, Dagl Β, and mgll in Pat.']	N/A	N/A	[('UBERON_0007023', 'adult organism', 4, 'adult'), ('GO_0010467', 'gene expression', 90, 'gene expression'), ('SO_0000704', 'gene', 90, 'gene'), ('CHEBI_67194', 'cannabinoid', 113, 'cannabinoid'), ('PR_000004968', 'calretinin', 144, 'Cnr2'), ('UBERON_0001898', 'hypothalamus', 156, 'hypothalamus'), ('GO_0010467', 'gene expression', 193, 'gene expression'), ('SO_0000704', 'gene', 193, 'gene'), ('GO_0008152', 'metabolic process', 221, 'metabolizing'), ('PR_000011593', 'ovarian cancer-related protein 1', 242, 'Napepld'), ('UBERON_0002107', 'liver', 253, 'liver'), ('PR_000006490', 'solute carrier family 49 member 4', 270, 'Dagl α'), ('PR_000006447', 'diacylglycerol kinase eta', 278, 'Dagl β'), ('UBERON_0004363', 'pharyngeal arch artery', 298, 'PAT')]
PMC5187359	12/2016	S297-PMC5187359	['the Hypothalamus is able to cross-talk to other Metabolically relevant Tissues such as Liver and Adipose Tissue through Sympathetic Circuits and circulating signals (leptin, Insulin, Cck, Neurotrophins, Il-6) by the Homeostatic Regulation Of the Endocannabinoid Signaling system (das,2010; maccarrone et al.,2014; seoane-collazo et al.,2015).']	N/A	N/A	[('UBERON_0001898', 'hypothalamus', 4, 'hypothalamus'), ('GO_0008152', 'metabolic process', 48, 'metabolically'), ('UBERON_0000479', 'tissue', 71, 'tissues'), ('UBERON_0002107', 'liver', 87, 'liver'), ('UBERON_0001013', 'adipose tissue', 97, 'adipose tissue'), ('UBERON_0003929', 'digestive tract epithelium', 120, 'sympathetic circuits'), ('PR_000045358', 'insulin family protein', 174, 'insulin'), ('PR_000005255', 'cyclin-dependent kinase 2-associated protein 2', 183, 'CCK'), ('PR_000021998', 'neurotrophin', 188, 'neurotrophins'), ('PR_000001470', 'interleukin-28B', 203, 'IL-6'), ('GO_0042592', 'homeostatic process', 216, 'homeostatic'), ('GO_0065007', 'biological regulation', 228, 'regulation of ...'), ('CHEBI_67198', 'retinoic acid receptor agonist', 246, 'endocannabinoid'), ('GO_0038002', 'endocrine signaling', 246, 'endocannabinoid signaling')]
PMC5367805	3/2017	S6-PMC5367805	['2-ag, aa and nae levels were measured in Hypothalamus, hippocampus and Olfactory Bulb of the offspring.']	N/A	N/A	[('UBERON_0001898', 'hypothalamus', 41, 'hypothalamus'), ('GO_0007608', 'sensory perception of smell', 71, 'olfactory'), ('UBERON_0002264', 'olfactory bulb', 71, 'olfactory bulb')]
PMC5367805	3/2017	S9-PMC5367805	['in Hypothalamus, r male offspring displayed decreased levels of aa and oea, with no change in the levels of the Endocannabinoids 2-Ag and aea.']	N/A	N/A	[('UBERON_0001898', 'hypothalamus', 3, 'hypothalamus'), ('CHEBI_50904', 'allergen', 112, 'endocannabinoids'), ('CHEBI_51383', 'hydridocarbon(3.)', 129, '2-AG')]
PMC5367805	3/2017	S41-PMC5367805	['moreover, exposure to a maternal diet rich in N-3 or N-6 Fatty Acids modifies arachidonic acid and/or Endocannabinoid levels in neonatal Hypothalamus and hippocampus, resulting in alterations in the Hypothalamus- Pituitary-Adrenal axis functions [44].']	N/A	N/A	[('CHEBI_30256', 'thiocarbonyl group', 46, 'n-3'), ('CHEBI_35418', 'N-acetylneuraminate', 53, 'n-6 fatty acids'), ('CHEBI_67198', 'retinoic acid receptor agonist', 102, 'endocannabinoid'), ('UBERON_0001898', 'hypothalamus', 137, 'hypothalamus'), ('UBERON_0001898', 'hypothalamus', 199, 'hypothalamus'), ('UBERON_0002109', 'pair of nares', 213, 'pituitary'), ('UBERON_0002369', 'adrenal gland', 223, 'adrenal')]
PMC5367805	3/2017	S71-PMC5367805	['for the isolation of the selected Brain Regions, Brains were thawed in cold Tris-Hcl buffer (50 mm, ph = 7.4) and the entire Hypothalamus, right hippocampus and right Olfactory Bulb was quickly dissected and immediately frozen at −80°c until Lipid extraction.']	N/A	N/A	[('UBERON_0002616', 'regional part of brain', 34, 'brain regions'), ('UBERON_0000955', 'brain', 49, 'brains'), ('CHEBI_9754', 'tris', 76, 'Tris'), ('CHEBI_17883', 'hydrogen chloride', 81, 'HCl'), ('UBERON_0001898', 'hypothalamus', 125, 'hypothalamus'), ('GO_0007608', 'sensory perception of smell', 167, 'olfactory'), ('UBERON_0002264', 'olfactory bulb', 167, 'olfactory bulb'), ('CHEBI_18059', 'lipid', 242, 'lipid')]
PMC5367805	3/2017	S80-PMC5367805	['the concentrations of internal standards, as well as the calibration curves, were set and tailored using test Hypothalamus, Hippocampal and Olfactory Bulb Tissues.']	N/A	N/A	[('UBERON_0001898', 'hypothalamus', 110, 'hypothalamus'), ('UBERON_0001954', "Ammon's horn", 124, 'hippocampal'), ('GO_0007608', 'sensory perception of smell', 140, 'olfactory'), ('UBERON_0002264', 'olfactory bulb', 140, 'olfactory bulb'), ('UBERON_0000479', 'tissue', 155, 'tissues')]
PMC5367805	3/2017	S112-PMC5367805	['Anandamide (Aea), 2-Arachidonoylglycerol (2-Ag), arachidonic acid (Aa), Oleoylethanolamide (oea) and Palmitoylethanolamide (Pea) levels in the Hypothalamus of male offspring (a-e) from control dams (n = 14) and calorie-restricted dams (n = 14) at Birth (open bars and solid bars, respectively).']	N/A	N/A	[('CHEBI_2704', 'anastrozole', 0, 'Anandamide'), ('CHEBI_39048', 'ADA', 12, 'AEA'), ('CHEBI_52392', '2-arachidonoylglycerol', 18, '2-arachidonoylglycerol'), ('CHEBI_51383', 'hydridocarbon(3.)', 42, '2-AG'), ('CHEBI_27718', "alpha-Fuc-(1->2)-[alpha-Fuc-(1->2)-beta-Gal-(1->3)-alpha-GalNAc-(1->3)]-beta-Gal-(1->4)-beta-GlcNAc-(1->3)-beta-Gal-(1->4)-beta-Glc-(1<->1')-Cer", 67, 'AA'), ('CHEBI_71466', 'oleoyl ethanolamide', 72, 'oleoylethanolamide'), ('CHEBI_71464', 'palmitoyl ethanolamide', 101, 'palmitoylethanolamide'), ('CHEBI_39015', 'apolipoprotein', 124, 'PEA'), ('UBERON_0001898', 'hypothalamus', 143, 'hypothalamus'), ('GO_0007567', 'parturition', 247, 'birth')]
PMC5367805	3/2017	S114-PMC5367805	['data were analyzed by student´s t -test (a, b) or mann whitney´s u test (c, d, e): * p<0.05.10.1371/journal.pone.0174307.g003\n\ncaption (fig): fig 3\nEndocannabinoid and Endocannabinoid-related Lipid levels in the Hypothalamus of female offspring at Birth.']	N/A	N/A	[('CHEBI_84903', '22-methyltricosanoic acid', 148, 'Endocannabinoid'), ('CHEBI_67198', 'retinoic acid receptor agonist', 168, 'endocannabinoid'), ('CHEBI_18059', 'lipid', 192, 'lipid'), ('UBERON_0001898', 'hypothalamus', 212, 'hypothalamus'), ('GO_0007567', 'parturition', 248, 'birth')]
PMC5367805	3/2017	S115-PMC5367805	['Anandamide (Aea), 2-Arachidonoylglycerol (2-Ag), arachidonic acid (Aa) and Palmitoylethanolamide (Pea) levels in the Hypothalamus of female offspring (a-d) from control dams (n = 10) and calorie-restricted dams (n = 10) at Birth (open bars and solid bars, respectively).']	N/A	N/A	[('CHEBI_2704', 'anastrozole', 0, 'Anandamide'), ('CHEBI_39048', 'ADA', 12, 'AEA'), ('CHEBI_52392', '2-arachidonoylglycerol', 18, '2-arachidonoylglycerol'), ('CHEBI_51383', 'hydridocarbon(3.)', 42, '2-AG'), ('CHEBI_27718', "alpha-Fuc-(1->2)-[alpha-Fuc-(1->2)-beta-Gal-(1->3)-alpha-GalNAc-(1->3)]-beta-Gal-(1->4)-beta-GlcNAc-(1->3)-beta-Gal-(1->4)-beta-Glc-(1<->1')-Cer", 67, 'AA'), ('CHEBI_71464', 'palmitoyl ethanolamide', 75, 'palmitoylethanolamide'), ('CHEBI_39015', 'apolipoprotein', 98, 'PEA'), ('UBERON_0001898', 'hypothalamus', 117, 'hypothalamus'), ('GO_0007567', 'parturition', 223, 'birth')]
PMC5367805	3/2017	S230-PMC5367805	['caption (supplementary-material): s2 data\nEndocannabinoid and Endocannabinoid-related Lipid levels in Hypothalamus.']	N/A	N/A	[('CHEBI_84903', '22-methyltricosanoic acid', 42, 'Endocannabinoid'), ('CHEBI_67198', 'retinoic acid receptor agonist', 62, 'endocannabinoid'), ('CHEBI_18059', 'lipid', 86, 'lipid'), ('UBERON_0001898', 'hypothalamus', 102, 'hypothalamus')]
PMC5385335	4/2017	S151-PMC5385335	['the neurochemical switch operated by cck on van determines an anorexigenic vs orexigenic phenotype that mediates an appropriate response at the Brain Stem and Hypothalamic levels to Regulate fi (14,15).']	N/A	N/A	[('UBERON_0002298', 'brainstem', 144, 'brain stem'), ('UBERON_0001898', 'hypothalamus', 159, 'hypothalamic'), ('GO_0065007', 'biological regulation', 182, 'regulate')]
PMC5445052	4/2017	S17-PMC5445052	['in Mammals, a central pacemaker located in the Suprachiasmatic Nuclei of the anterior Hypothalamus coordinates the timing of these Rhythms.']	N/A	N/A	[('NCBITaxon_40674', 'Mammalia', 3, 'mammals'), ('UBERON_0001929', 'supraoptic nucleus', 47, 'suprachiasmatic nuclei'), ('UBERON_0001898', 'hypothalamus', 86, 'hypothalamus'), ('GO_0006281', 'DNA repair', 131, 'rhythms')]
PMC5445052	4/2017	S165-PMC5445052	['c , chow; e2, Estradiol; fsh , follicle-stimulating hormone; hf , high fat; H&e , Hematoxylin and eosin; hpg , Hypothalamic–Pituitary–Gonadal; igf2 , Insulin-Like Growth Factor 2; igf2r , Insulin-Like Growth Factor 2 Receptor; lh , Luteinizing hormone; pnd , Postnatal day; sd , sprague-dawley.']	N/A	N/A	[('CHEBI_4856', 'esmolol', 14, 'Estradiol'), ('CHEBI_51686', 'haematoxylin', 76, 'H'), ('CHEBI_51686', 'haematoxylin', 82, 'hematoxylin'), ('UBERON_0001898', 'hypothalamus', 111, 'hypothalamic'), ('UBERON_0002109', 'pair of nares', 124, 'pituitary'), ('UBERON_0000991', 'gonad', 134, 'gonadal'), ('PR_000008959', 'immunoglobulin heavy constant gamma 1', 150, 'insulin-like growth factor 2'), ('PR_000001364', 'interleukin-1 receptor type II', 188, 'insulin-like growth factor 2 receptor'), ('GO_0001905', 'activation of membrane attack complex', 232, 'luteinizing'), ('GO_0007567', 'parturition', 259, 'postnatal')]
PMC5526786	8/2017	S67-PMC5526786	['in high Salt Intake of Salt-sensitive Individuals this endogenous cardiotonic Steroid is Secreted by the Adrenal Glands and the Hypothalamus following elevation of Plasma and Cerebrospinal Fluid na+.']	N/A	N/A	[('CHEBI_24866', 'salt', 8, 'salt'), ('GO_0007631', 'feeding behavior', 13, 'intake'), ('CHEBI_24866', 'salt', 23, 'salt'), ('NCBITaxon_1', 'root', 38, 'individuals'), ('CHEBI_35341', 'steroid', 78, 'steroid'), ('GO_0046903', 'secretion', 89, 'secreted'), ('UBERON_0002369', 'adrenal gland', 105, 'adrenal glands'), ('UBERON_0001898', 'hypothalamus', 128, 'hypothalamus'), ('UBERON_0001969', 'blood plasma', 164, 'plasma'), ('UBERON_0001359', 'cerebrospinal fluid', 175, 'cerebrospinal fluid')]
PMC5526786	8/2017	S72-PMC5526786	['in patients with essential hypertension eo is found to accumulate in those Tissues responsible for Blood Pressure Regulation (e.g Kidneys, Hypothalamus and Posterior Pituitary).']	N/A	N/A	[('UBERON_0000479', 'tissue', 75, 'tissues'), ('GO_0008217', 'regulation of blood pressure', 99, 'blood pressure regulation'), ('UBERON_0000178', 'blood', 99, 'blood'), ('UBERON_0002113', 'kidney', 130, 'kidneys'), ('UBERON_0001898', 'hypothalamus', 139, 'hypothalamus'), ('UBERON_0002198', 'neurohypophysis', 156, 'posterior pituitary')]
PMC5526977	7/2017	S15-PMC5526977	['for example, maternal hfd stimulates Hypothalamic Neurogenesis of Orexigenic Neuropeptide Y (Npy) Neurons and suppresses anorexigenic proopiomelanocortin (pomc) Neurons in male offspring12, which favors hyperphagia.']	N/A	N/A	[('UBERON_0001898', 'hypothalamus', 37, 'hypothalamic'), ('GO_0022008', 'neurogenesis', 50, 'neurogenesis'), ('GO_0042476', 'odontogenesis', 66, 'orexigenic'), ('PR_000012059', 'oncostatin-M', 66, 'orexigenic neuropeptide Y'), ('PR_000011368', 'N-acetylneuraminate lyase', 93, 'NPY'), ('CL_0000540', 'neuron', 98, 'neurons'), ('CL_0000540', 'neuron', 161, 'neurons')]
PMC5526977	7/2017	S275-PMC5526977	['Erα-mediated Control Of arc Gene Expression is a primary mechanism to Modulate Hypothalamic and Homeostatic functions79.']	N/A	N/A	[('PR_000007120', 'ephrin type-A receptor 1', 0, 'ERα'), ('GO_0010468', 'regulation of gene expression', 13, 'control of ... gene expression'), ('SO_0000704', 'gene', 28, 'gene'), ('GO_0065007', 'biological regulation', 70, 'modulate'), ('UBERON_0001898', 'hypothalamus', 79, 'hypothalamic'), ('GO_0042592', 'homeostatic process', 96, 'homeostatic')]
PMC5593991	9/2017	S100-PMC5593991	['three out of five Npy receptor Genes are widely Expressed together with Npy in the Mouse Brain, including Amygdala, Hypothalamus, and Areas Of the Striatum (e.g.']	N/A	N/A	[('PR_000011368', 'N-acetylneuraminate lyase', 18, 'NPY'), ('SO_0000704', 'gene', 31, 'genes'), ('GO_0010467', 'gene expression', 48, 'expressed'), ('PR_000011509', 'nuclear pore complex protein Nup155', 72, 'Npy'), ('NCBITaxon_10088', 'Mus <genus>', 83, 'mouse'), ('UBERON_0000955', 'brain', 89, 'brain'), ('UBERON_0001876', 'amygdala', 106, 'amygdala'), ('UBERON_0001898', 'hypothalamus', 116, 'hypothalamus'), ('UBERON_0013538', 'Brodmann (1909) area 7', 134, 'areas of ... striatum')]
PMC5593991	9/2017	S234-PMC5593991	['Brains were later sliced using a cryostat (leica 3500\u2009m) and 1 mm micro-punches were pooled for Amygdala and Hypothalamus respectively according to the Mouse Brain in stereotaxic coordinates75.']	N/A	N/A	[('UBERON_0000955', 'brain', 0, 'Brains'), ('UBERON_0001876', 'amygdala', 96, 'amygdala'), ('UBERON_0001898', 'hypothalamus', 109, 'hypothalamus'), ('NCBITaxon_10088', 'Mus <genus>', 152, 'Mouse'), ('UBERON_0000955', 'brain', 158, 'Brain')]
PMC5593991	9/2017	S251-PMC5593991	['quantitative pcr in Amygdala and Hypothalamus\neighty ng of total rna was converted to cdna using the high capacity cdna reverse transcriptase kit (thermofisher scientific, ma, usa).']	N/A	N/A	[('UBERON_0001876', 'amygdala', 20, 'amygdala'), ('UBERON_0001898', 'hypothalamus', 33, 'hypothalamus')]
PMC5644840	4/2014	S26-PMC5644840	['chronic stress and the hyperactivation of the Hypothalamic-Pituitary-Adrenal (hpa) axis is another common feature in obesity, and Cortisol is a potent hormone affecting early development.']	N/A	N/A	[('UBERON_0001898', 'hypothalamus', 46, 'hypothalamic'), ('UBERON_0002109', 'pair of nares', 59, 'pituitary'), ('UBERON_0002369', 'adrenal gland', 69, 'adrenal'), ('CHEBI_17650', 'cortisol', 130, 'cortisol')]
PMC5727393	12/2017	S24-PMC5727393	['freezing-specific behavior is rescued through intranasal Oxytocin or Chemogenetic activation of Hypothalamic Oxytocinergic Neurons.']	N/A	N/A	[('CHEBI_7872', 'oxytocin', 57, 'oxytocin'), ('GO_0051216', 'cartilage development', 69, 'chemogenetic'), ('CL_0000743', 'hypertrophic chondrocyte', 96, 'hypothalamic oxytocinergic neurons'), ('UBERON_0001898', 'hypothalamus', 96, 'hypothalamic')]
PMC5727393	12/2017	S25-PMC5727393	['acute intranasal Oxytocin successfully localizes to multiple Brain Regions, including the Anterior Cingulate Cortex (Acc), Amygdala, and Hypothalamus.']	N/A	N/A	[('CHEBI_7872', 'oxytocin', 17, 'oxytocin'), ('UBERON_0002616', 'regional part of brain', 61, 'brain regions'), ('UBERON_0009835', 'anterior cingulate cortex', 90, 'anterior cingulate cortex'), ('UBERON_2005026', 'primary head sinus', 117, 'ACC'), ('UBERON_0001876', 'amygdala', 123, 'amygdala'), ('UBERON_0001898', 'hypothalamus', 137, 'hypothalamus')]
PMC5727393	12/2017	S117-PMC5727393	['i125-labeled Oxytocin was detected robustly within the Blood and Olfactory Bulbs, and was distributed throughout the Brain, including Anterior Olfactory Nucleus, Anterior Cingulate Cortex (Acc), Nucleus Accumbens, Amygdala, and Hypothalamus (table\xa01).']	N/A	N/A	[('CHEBI_7872', 'oxytocin', 13, 'oxytocin'), ('UBERON_0000178', 'blood', 55, 'blood'), ('GO_0007608', 'sensory perception of smell', 65, 'olfactory'), ('UBERON_0002264', 'olfactory bulb', 65, 'olfactory bulbs'), ('UBERON_0000955', 'brain', 117, 'brain'), ('UBERON_0002870', 'dorsal motor nucleus of vagus nerve', 134, 'anterior olfactory nucleus'), ('GO_0007608', 'sensory perception of smell', 143, 'olfactory'), ('UBERON_0009835', 'anterior cingulate cortex', 162, 'anterior cingulate cortex'), ('UBERON_2005026', 'primary head sinus', 189, 'ACC'), ('UBERON_0001882', 'nucleus accumbens', 195, 'nucleus accumbens'), ('UBERON_0001876', 'amygdala', 214, 'amygdala'), ('UBERON_0001898', 'hypothalamus', 228, 'hypothalamus')]
PMC5727393	12/2017	S253-PMC5727393	['the Acc and Cea are two primary targets of Hypothalamic Oxytocinergic Neurons36, and Oxytocin enhances the functional connectivity between these regions14,65.']	N/A	N/A	[('UBERON_2005026', 'primary head sinus', 4, 'ACC'), ('UBERON_2000033', 'intermediate cell mass of mesoderm', 12, 'CeA'), ('CL_0000286', 'hyphal cell', 43, 'hypothalamic'), ('UBERON_0001898', 'hypothalamus', 43, 'hypothalamic'), ('CL_0002195', 'hepatic stem cell', 56, 'oxytocinergic neurons36'), ('CHEBI_7872', 'oxytocin', 85, 'oxytocin')]
PMC5727393	12/2017	S380-PMC5727393	['male oxt-Ires-cre/+ Mice (7–8 weeks old) were sedated with a Ketamine:xylazine Cocktail (100:10\u2009mg/kg) and bilateral burr holes were created above the Paraventricular Nuclei (Pvn) of the Hypothalamus.']	N/A	N/A	[('SO_0000243', 'internal_ribosome_entry_site', 9, 'IRES'), ('NCBITaxon_10088', 'Mus <genus>', 20, 'mice'), ('CHEBI_6121', 'ketamine', 61, 'ketamine'), ('CHEBI_60004', 'mixture', 79, 'cocktail'), ('UBERON_0001920', 'paraventricular nucleus of thalamus', 151, 'paraventricular nuclei'), ('UBERON_0009910', 'posterior lateral plate mesoderm', 175, 'PVN'), ('UBERON_0001898', 'hypothalamus', 187, 'hypothalamus')]
PMC5727393	12/2017	S393-PMC5727393	['free-floating coronal sections containing the Pvn Hypothalamus were incubated for 3\u2009h in blocking Solution containing 0.2% Triton x-100, 2% normal Horse Serum, and 0.05% Tween20.']	N/A	N/A	[('UBERON_0009910', 'posterior lateral plate mesoderm', 46, 'PVN'), ('UBERON_0001898', 'hypothalamus', 50, 'hypothalamus'), ('CHEBI_75958', 'solution', 98, 'solution'), ('CHEBI_29236', 'protium atom', 123, 'Triton'), ('NCBITaxon_1', 'root', 147, 'horse'), ('UBERON_0001977', 'blood serum', 153, 'serum'), ('CHEBI_53424', 'polysorbate 20', 170, 'Tween20')]
PMC5804527	8/2016	S70-PMC5804527	['these regions include, but are not limited to, Limbic structures such as the Amygdala and hippocampus, as well as Hypothalamic nuclei [63,67,68].']	N/A	N/A	[('UBERON_0000349', 'limbic system', 47, 'limbic'), ('UBERON_0001876', 'amygdala', 77, 'amygdala'), ('UBERON_0001898', 'hypothalamus', 114, 'hypothalamic')]
PMC5804527	8/2016	S123-PMC5804527	['Neuropeptide Y\nNpy, a 36 amino acid peptide highly Expressed in Limbic Regions Of the Brain, including the Hypothalamus and Amygdala, as well as the hippocampus [146], was isolated in 1982 at karolinska institutet, stockholm, sweden by tatemoto and co-workers [147].']	N/A	N/A	[('PR_000011046', 'nuclear receptor coactivator 7', 0, 'Neuropeptide Y'), ('PR_000011368', 'N-acetylneuraminate lyase', 15, 'NPY'), ('GO_0010467', 'gene expression', 51, 'expressed'), ('UBERON_0002616', 'regional part of brain', 64, 'limbic regions of ... brain'), ('UBERON_0001898', 'hypothalamus', 107, 'hypothalamus'), ('UBERON_0001876', 'amygdala', 124, 'amygdala')]
PMC5804527	8/2016	S127-PMC5804527	['the activity within the Hypothalamus is further Modulated by the Hindbrain and Limbic structures [151].']	N/A	N/A	[('UBERON_0001898', 'hypothalamus', 24, 'hypothalamus'), ('GO_0065007', 'biological regulation', 48, 'modulated'), ('UBERON_0002028', 'hindbrain', 65, 'hindbrain'), ('UBERON_0000349', 'limbic system', 79, 'limbic')]
PMC5804527	8/2016	S131-PMC5804527	['within the Hypothalamus, crh is produced in the Paraventricular Nucleus, and is catabolic, as well as anorectic [163–165].']	N/A	N/A	[('UBERON_0001898', 'hypothalamus', 11, 'hypothalamus'), ('UBERON_0001930', 'paraventricular nucleus of hypothalamus', 48, 'paraventricular nucleus')]
PMC5804527	8/2016	S132-PMC5804527	['additionally, crh in the Hypothalamus Regulates the hpa-axis and functions as a “relay” between central and peripheral actions [166].']	N/A	N/A	[('UBERON_0001898', 'hypothalamus', 25, 'hypothalamus'), ('GO_0065007', 'biological regulation', 38, 'regulates')]
